Search

Your search keyword '"I. Hansen"' showing total 651 results
Start Over Author "I. Hansen"

Refine your results

more »

more »

more »

more »

more »
651 results on '"I. Hansen"'

1. Clinical added value of MRI to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): study protocol for an international multicentre prospective diagnostic accuracy study

Author

B. Görgec, I. Hansen, G. Kemmerich, T. Syversveen, M. Abu Hilal, E. J. T. Belt, R. H. C. Bisschops, T. L. Bollen, K. Bosscha, M. C. Burgmans, V. Cappendijk, M. T. De Boer, M. D’Hondt, B. Edwin, H. Gielkens, D. J. Grünhagen, P. Gillardin, P. D. Gobardhan, H. H. Hartgrink, K. Horsthuis, N. F. M. Kok, P. A. M. Kint, J. W. H. Kruimer, W. K. G. Leclercq, D. J. Lips, B. Lutin, M. Maas, H. A. Marsman, M. Morone, J. P. Pennings, J. Peringa, W. W. Te Riele, M. Vermaas, D. Wicherts, F. E. J. A. Willemssen, B. M. Zonderhuis, P. M. M. Bossuyt, R. J. Swijnenburg, Å. A. Fretland, C. Verhoef, M. G. Besselink, J. Stoker, and for the CAMINO Study Group

Subjects
Colorectal cancer, Colorectal liver metastases, Liver metastases, Liver MRI, Abdominal CT scan, Diffusion weighted imaging, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Abstract Background Abdominal computed tomography (CT) is the standard imaging method for patients with suspected colorectal liver metastases (CRLM) in the diagnostic workup for surgery or thermal ablation. Diffusion-weighted and gadoxetic-acid-enhanced magnetic resonance imaging (MRI) of the liver is increasingly used to improve the detection rate and characterization of liver lesions. MRI is superior in detection and characterization of CRLM as compared to CT. However, it is unknown how MRI actually impacts patient management. The primary aim of the CAMINO study is to evaluate whether MRI has sufficient clinical added value to be routinely added to CT in the staging of CRLM. The secondary objective is to identify subgroups who benefit the most from additional MRI. Methods In this international multicentre prospective incremental diagnostic accuracy study, 298 patients with primary or recurrent CRLM scheduled for curative liver resection or thermal ablation based on CT staging will be enrolled from 17 centres across the Netherlands, Belgium, Norway, and Italy. All study participants will undergo CT and diffusion-weighted and gadoxetic-acid enhanced MRI prior to local therapy. The local multidisciplinary team will provide two local therapy plans: first, based on CT-staging and second, based on both CT and MRI. The primary outcome measure is the proportion of clinically significant CRLM (CS-CRLM) detected by MRI not visible on CT. CS-CRLM are defined as liver lesions leading to a change in local therapeutical management. If MRI detects new CRLM in segments which would have been resected in the original operative plan, these are not considered CS-CRLM. It is hypothesized that MRI will lead to the detection of CS-CRLM in ≥10% of patients which is considered the minimal clinically important difference. Furthermore, a prediction model will be developed using multivariable logistic regression modelling to evaluate the predictive value of patient, tumor and procedural variables on finding CS-CRLM on MRI. Discussion The CAMINO study will clarify the clinical added value of MRI to CT in patients with CRLM scheduled for local therapy. This study will provide the evidence required for the implementation of additional MRI in the routine work-up of patients with primary and recurrent CRLM for local therapy. Trial registration The CAMINO study was registered in the Netherlands National Trial Register under number NL8039 on September 20th 2019.

Published
2021
Full Text
View/download PDF

3. Sleep and cognition in Bipolar Disorder in full or partial remission

Author

K. T. Svee, H. Kallestad, G. Morken, T. I. Hansen, and A. Engum

Subjects
Psychiatry, RC435-571
Abstract

Introduction Cognitive impairment in Bipolar Disorder (BD) is frequent and is associated with reduced function in several areas. Close to half of the patients with BD have persistent cognitive dysfunction. The causes of cognitive impairments and factors associated with normal cognitive function are not clearly described. Some preliminary evidence links sleep disturbances and cognition impairment in BD. A limited number of studies have investigated the link between sleep and cognitive function in BD using objective measures. Objectives We aim to investigate associations between sleep and objective and subjective cognitive function in patients with BD in full or partial remission. Methods This is a cross-sectional study. The participants will be 90 adults meeting criteria for DSM 5 BD type 1 or type 2 in full or partial remission. Participants are recruited from psychoeducational groups for BD and from a specialist outpatient clinic. Diagnoses are set with SCID-5 and are confirmed in a consensus meeting with at least two psychiatrists and/or specialists in psychology. Symptoms of depression and mania are measured with Montgomery Asberg depression rating scale (MADRS) and Young Mania Rating Scale (YMRS). Sleep is measured subjectively with Insomnia Severity Index (ISI) and objectively with actigraphs which participants wear on their non-dominant hand for ten days. Subjective cognition is measured with Cognitive Complaints in Bipolar Disorder Rating Assessment (COBRA). Participants undergo neurocognitive testing with a self-administered validated web-based neuropsychological test platform. The testing is carried out in the participant’s home on their smart phones. The tests include measures of learning, storing, recalling, and recognizing visual and verbal information, working memory and reaction time. Normal cognitive function is defined as scores within or above mean on all cognitive subtests. The test-platform has been validated. We will use descriptive statistics to examine distribution of demographic characteristics. We will test for correlations between sleep factors and subjective and objective measures of cognitive function. Ethics The Regional Committees for Medical and Health research ethics approved the study. Results Results will be presented at the conference. So far, 74 out of 90 participants have been included. Conclusions We anticipate that normal sleep may be associated with good cognitive functioning. The findings of this study could offer supplementary insights into BD heterogeneity and potential treatment targets. Abbreviations: SCID-5, Structured Clinical Interview for DSM-5 Disclosure of Interest None Declared

Published
2024
Full Text
View/download PDF

4. A method for synchronized use of EEG and eye tracking in fully immersive VR

Author

Olav F. P. Larsen, William G. Tresselt, Emanuel A. Lorenz, Tomas Holt, Grethe Sandstrak, Tor I. Hansen, Xiaomeng Su, and Alexander Holt

Subjects
electroencephalography, eye-tracking, virtual reality, brain-computer interface, speller, synchronization, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571
Abstract

This study explores the synchronization of multimodal physiological data streams, in particular, the integration of electroencephalography (EEG) with a virtual reality (VR) headset featuring eye-tracking capabilities. A potential use case for the synchronized data streams is demonstrated by implementing a hybrid steady-state visually evoked potential (SSVEP) based brain-computer interface (BCI) speller within a fully immersive VR environment. The hardware latency analysis reveals an average offset of 36 ms between EEG and eye-tracking data streams and a mean jitter of 5.76 ms. The study further presents a proof of concept brain-computer interface (BCI) speller in VR, showcasing its potential for real-world applications. The findings highlight the feasibility of combining commercial EEG and VR technologies for neuroscientific research and open new avenues for studying brain activity in ecologically valid VR environments. Future research could focus on refining the synchronization methods and exploring applications in various contexts, such as learning and social interactions.

Published
2024
Full Text
View/download PDF

7. Contributions of the NICHD neonatal research network's generic database to documenting and advancing the outcomes of extremely preterm infants

Author

Edward F. Bell, Barbara J. Stoll, Nellie I. Hansen, Myra H. Wyckoff, Michele C. Walsh, Pablo J. Sánchez, Matthew A. Rysavy, Jenna H. Gabrio, Stephanie W. Archer, Abhik Das, and Rosemary D. Higgins

Subjects
Infant, Extremely Premature, Pediatrics, Perinatology and Child Health, Infant, Newborn, Obstetrics and Gynecology, Humans, Infant, National Institute of Child Health and Human Development (U.S.), Gestational Age, Infant, Premature, Diseases, Prospective Studies, Child, United States
Abstract

The Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network (NRN) maintains a database of extremely preterm infants known as the Generic Database (GDB). Begun in 1987, this database now includes more than 91,000 infants, most of whom are extremely preterm (29 weeks gestation). The GDB has been the backbone of the NRN, providing high quality, prospectively collected data to study the changing epidemiology of extreme prematurity and its outcomes over time. In addition, GDB data have been used to generate hypotheses for prospective studies and to develop new clinical trials by providing information about the numbers and characteristics of available subjects and the expected event rates for conditions and complications to be studied. Since its inception, the GDB has been the basis of more than 200 publications in peer-reviewed journals, many of which have had a significant impact on the field of neonatology.

Published
2023

9. Associations between feeding practices and growth and neurodevelopmental outcomes at 36 months among children living in low- and low-middle income countries who participated in the BRAIN-HIT trial

Author

Barbara T. Do, Nellie I. Hansen, Carla Bann, Rebecca L. Lander, Shivaprasad S. Goudar, Omrana Pasha, Elwyn Chomba, Sangappa M. Dhaded, Vanessa R. Thorsten, Jan L. Wallander, Fred J. Biasini, Richard Derman, Robert L. Goldenberg, and Waldemar A. Carlo

Subjects
Bayley scores of infant development, Developmental outcome, Stunting, Wasting, Dietary diversity, Low- and middle-income countries, Nutrition. Foods and food supply, TX341-641, Food processing and manufacture, TP368-456, Medicine (General), R5-920
Abstract

Abstract Background Feeding practices over the first several years of a child’s life can critically influence development. The purpose of this study was to examine associations between feeding practices and growth and neurodevelopmental outcomes at 36 months of age among children from low- and low-middle-income countries (LMIC). Methods We conducted a secondary analysis using data collected from children in India, Pakistan, and Zambia who were enrolled in a randomized controlled trial of a home-based early development intervention program called Brain Research to Ameliorate Impaired Neurodevelopment Home-based Intervention Trial. Qualitative dietary data collected at 36 months was used to assess the modified Minimum Acceptable Diet (mMAD), a measure based on a core indicator developed by the World Health Organization to measure whether young children receive the minimum number of meals recommended and adequate diversity of major food groups in their diet. Regression models were used to assess cross-sectional associations between diet and growth indices, including Z-scores for height-for-age (HAZ), weight-for-age (WAZ), weight-for-height (WHZ), head circumference (HCZ), and Bayley Scales of Infant Development II mental and psychomotor developmental measures at 36 months of age. Results Of 371 children, 174 (47%) consumed the mMAD, with significantly higher mean adjusted WHZ than those who did not meet mMAD (0.20 vs − 0.08, p = 0.05). Egg consumption was found to be significantly associated with a decreased risk of wasting [adjusted RR (95% CI): 0.37 (0.15, 0.89), p = 0.03]. HCZ at 36 months did not differ significantly for children who did and did not receive the mMAD. Conclusion Meeting the mMAD was associated with better weight-for-height outcomes at 36 months in children in these three LMIC, highlighting the importance of adequate food quantity and quality. Trial registration NCT00639184 registered on March 20, 2008.

Published
2018
Full Text
View/download PDF

10. Risk factors for possible serious bacterial infection in a rural cohort of young infants in central India

Author

Marie E. Wang, Archana B. Patel, Nellie I. Hansen, Lauren Arlington, Amber Prakash, and Patricia L. Hibberd

Subjects
Cohort, Possible serious bacterial infection, Young infant, India, Public aspects of medicine, RA1-1270
Abstract

Abstract Background Possible serious bacterial infection (PBSI) is a major cause of neonatal mortality worldwide. We studied risk factors for PSBI in a large rural population in central India where facility deliveries have increased as a result of a government financial assistance program. Methods We studied 37,379 pregnant women and their singleton live born infants with birth weight ≥ 1.5 kg from 20 rural primary health centers around Nagpur, India, using data from the 2010–13 population-based Maternal and Newborn Health Registry supported by NICHD’s Global Network for Women’s and Children’s Health Research. Factors associated with PSBI were identified using multivariable Poisson regression. Results Two thousand one hundred twenty-three infants (6 %) had PSBI. Risk factors for PSBI included nulliparity (RR 1.13, 95 % CI 1.03–1.23), parity > 2 (RR 1.30, 95 % CI 1.07–1.57) compared to parity 1–2, first antenatal care visit in the 2nd/3rd trimester (RR 1.46, 95 % CI 1.08–1.98) compared to 1st trimester, administration of antenatal corticosteroids (RR 2.04, 95 % CI 1.60–2.61), low birth weight (RR 3.10, 95 % CI 2.17–4.42), male sex (RR 1.20, 95 % CI 1.10–1.31) and lack of early initiation of breastfeeding (RR 3.87, 95 % CI 2.69–5.58). Conclusion Infants who are low birth weight, born to mothers who present late to antenatal care or receive antenatal corticosteroids, or born to nulliparous women or those with a parity > 2, could be targeted for interventions before and after delivery to improve early recognition of signs and symptoms of PSBI and prompt referral. There also appears to be a need for a renewed focus on promoting early initiation of breastfeeding following delivery in facilities. Trial registration This trial is registered at ClinicalTrials.gov ( NCT01073475 ).

Published
2016
Full Text
View/download PDF

14. Antimicrobial Susceptibility Profiles Among Neonatal Early-onset Sepsis Pathogens

Author

Pablo J. Sánchez, Dustin D Flannery, Jeffrey S. Gerber, Nellie I. Hansen, Barbara J. Stoll, and Karen M. Puopolo

Subjects
Microbiology (medical), medicine.medical_specialty, Birth weight, Antimicrobial susceptibility, Gestational Age, Microbial Sensitivity Tests, Article, Sepsis, Anti-Infective Agents, Ampicillin, Internal medicine, medicine, Humans, Prospective Studies, Retrospective Studies, Bacteria, business.industry, Infant, Newborn, medicine.disease, Antimicrobial, Anti-Bacterial Agents, Infectious Diseases, Pediatrics, Perinatology and Child Health, Gestation, Gentamicin, Gentamicins, Neonatal Sepsis, business, Empiric therapy, medicine.drug
Abstract

BACKGROUND: Empiric administration of ampicillin and gentamicin is recommended for newborns at risk of early-onset sepsis (EOS). There are limited data on antimicrobial susceptibility of all EOS pathogens. METHODS: Retrospective review of antimicrobial susceptibility data from a prospective EOS surveillance study of infants born ≥22 weeks’ gestation and cared for in Neonatal Research Network centers 4/2015–3/2017. Non-susceptible was defined as intermediate or resistant on final result. RESULTS: We identified 239 pathogens (235 bacteria, 4 fungi) in 235 EOS cases among 217,480 live-born infants. Antimicrobial susceptibility data were available for 189/239 (79.1%) isolates. Among 81 gram-positive isolates with ampicillin and/or gentamicin susceptibility data, all were susceptible in vitro to either ampicillin or gentamicin. Among gram-negative isolates with ampicillin and/or gentamicin susceptibility data, 72/94 (76.6%) isolates were non-susceptible to ampicillin, 8/94 (8.5%) were non-susceptible to gentamicin, and 7/96 (7.3%) isolates were non-susceptible to both. Five percent or less of tested gram-negative isolates were non-susceptible to each of 3(rd) or 4(th) generation cephalosporins, piperacillin-tazobactam and carbapenems. Overall, we estimated that 8% of EOS cases were caused by isolates non-susceptible to both ampicillin and gentamicin; these were most likely to occur among preterm, very-low birth weight infants. CONCLUSIONS: The vast majority of contemporary EOS pathogens are susceptible to the combination of ampicillin and gentamicin. Clinicians may consider the addition of broader-spectrum therapy among newborns at highest risk of EOS, but we caution that neither the substitution nor the addition of one single antimicrobial agent is likely to provide adequate empiric therapy in all cases.

Published
2021
Full Text
View/download PDF

15. [Massive pancarditis-autopsy report]

Author

T, Hansen, M, Otto, J, Pohl, G, Birkner, I, Hansen, U, Titze, and J, Kriegsmann

Abstract

We report on a 69-year-old man suffering from chronic progressive oligoarthritis (localized in metacarpal and knee joints), which clinically was interpreted as steroid-sensitive seronegative chronic arthritis. The patient died from sudden death at the emergency department after a 4-week history of increasing cough and dyspnea (meanwhile obtaining negative testing results for SARS-CoV-2). During the autopsy, we found massive pancarditis affecting all cardiac compartments, in particular exhibiting constrictive pericarditis, myocarditis, and multivalvular endocarditis. Microscopically, interstitial myocarditis could be observed. Performing extensive molecular analyses, we detected Tropheryma whipplei in the tissue specimens of the heart, but not in various duodenal tissue probes or in the synovial membrane. Taken together, in the present case the cause of death was acute cardiac failure due to multivalvular pancarditis due to T. whipplei. Besides from classical symptoms and morphological signs, Whipple's disease may present with various features. Regarding the differential diagnosis of a chronic multisystem disorder with aspects of hitherto unknown arthralgia, Whipple's disease should be considered.Wir berichten über einen 69-jährigen Patienten mit einer chronisch fortdauernden Oligoarthritis (Hand- und Kniegelenke), die klinisch als steroidsensible seronegative chronische Arthritis eingestuft wurde. Der Patient starb in der Notaufnahme am plötzlichen Herztod, nachdem er seit 4 Wochen unter Husten und Atemnot litt (SARS-CoV-2[„severe acute respiratory syndrome coronavirus 2“]-negativ getestet). Bei der Obduktion fand sich eine massive Pankarditis mit Pericarditis constrictiva, Myokarditis und multivalvulärer Endokarditis. Histologisch zeigte sich eine interstitielle Myokarditis. In einer ausführlichen molekularen Diagnostik konnte Tropheryma whipplei aus dem Herzgewebe gesichert werden, nicht aber aus der Synovialmembran und auch nicht aus diversen Duodenalbiopsien. Abschließend diagnostizierten wir als Todesursache eine akute kardiale Dekompensation bei einer durch Tropheryma whipplei ausgelösten multivalvulären Pankarditis als Todesursache. Dieser Fall untermauert das vielgestaltige klinische und morphologische Bild des Morbus Whipple. Bei einem unklaren chronifizierten Krankheitsprozess mit Hinweis auf eine Multisystemerkrankung unter Beteiligung des Gelenksystems sollte der Morbus Whipple in die Differenzialdiagnostik mit einbezogen werden.

Published
2022

16. Neonatal infections: Insights from a multicenter longitudinal research collaborative

Author

Dustin D. Flannery, Karen M. Puopolo, Nellie I. Hansen, Pablo J. Sánchez, and Barbara J. Stoll

Subjects
Antimicrobial Stewardship, Incidence, Pediatrics, Perinatology and Child Health, Infant, Newborn, Obstetrics and Gynecology, Humans
Abstract

For more than 30 years, the Neonatal Research Network (NRN) has conducted studies addressing the epidemiology of neonatal infections, including incidence, microbiology, maternal and neonatal risk factors, associated clinical findings, and outcomes. These studies have provided clinicians and policymakers critical data needed to inform national guidance for infection risk assessment and support daily practice. Further, NRN studies have prompted research into optimal approaches to infection diagnosis, treatment, and antimicrobial stewardship. In this article, we summarize the key findings of NRN infection-related studies, with an emphasis on those published in 2000 or later.

Published
2022

18. Neurodevelopmental outcomes following neonatal late-onset sepsis and blood culture-negative conditions

Author

Eric C. Eichenwald, Sara B. DeMauro, Karen M. Puopolo, Edward F. Bell, Pablo J. Sánchez, Scott A. Lorch, C. Michael Cotten, Barbara J. Stoll, Sagori Mukhopadhyay, Rachel G. Greenberg, and Nellie I. Hansen

Subjects
medicine.medical_specialty, Pediatrics, Developmental Disabilities, Birth weight, Perforation (oil well), Infant, Premature, Diseases, Article, Sepsis, Enterocolitis, Necrotizing, Risk Factors, Epidemiology, Humans, Medicine, Hospital Mortality, Neonatology, Age of Onset, Retrospective Studies, business.industry, Infant, Newborn, Obstetrics and Gynecology, Retrospective cohort study, General Medicine, medicine.disease, Anti-Bacterial Agents, Blood Culture, Intestinal Perforation, Infant, Extremely Premature, Relative risk, Pediatrics, Perinatology and Child Health, Gestation, Neonatal Sepsis, business, Infant, Premature
Abstract

ObjectiveDetermine risk of death or neurodevelopmental impairment (NDI) in infants with late-onset sepsis (LOS) versus late-onset, antibiotic-treated, blood culture-negative conditions (LOCNC).DesignRetrospective cohort study.Setting24 neonatal centres.PatientsInfants born 1/1/2006–31/12/2014, at 22–26 weeks gestation, with birth weight 401–1000 g and surviving >7 days were included. Infants with early-onset sepsis, necrotising enterocolitis, intestinal perforation or both LOS and LOCNC were excluded.ExposuresLOS and LOCNC were defined as antibiotic administration for ≥5 days with and without a positive blood/cerebrospinal fluid culture, respectively. Infants with these diagnoses were also compared with infants with neither condition.OutcomesDeath or NDI was assessed at 18–26 months corrected age follow-up. Modified Poisson regression models were used to estimate relative risks adjusting for covariates occurring ≤7 days of age.ResultsOf 7354 eligible infants, 3940 met inclusion criteria: 786 (20%) with LOS, 1601 (41%) with LOCNC and 1553 (39%) with neither. Infants with LOS had higher adjusted relative risk (95% CI) for death/NDI (1.14 (1.05 to 1.25)) and death before follow-up (1.71 (1.44 to 2.03)) than those with LOCNC. Among survivors, risk for NDI did not differ between the two groups (0.99 (0.86 to 1.13)) but was higher for LOCNC infants (1.17 (1.04 to 1.31)) compared with unaffected infants.ConclusionsInfants with LOS had higher risk of death, but not NDI, compared with infants with LOCNC. Surviving infants with LOCNC had higher risk of NDI compared with unaffected infants. Improving outcomes for infants with LOCNC requires study of the underlying conditions and the potential impact of antibiotic exposure.

Published
2021
Full Text
View/download PDF

19. Poor Response Inhibition and Symptoms of Inattentiveness Are Core Characteristics of Lifetime Illicit Substance Use among Young Adults in the General Norwegian Population: The HUNT Study

Author

A. D. F. Lauvsnes, T. I. Hansen, A. K. Håberg, R. W Gråwe, and M. Langaas

Subjects
Psychiatry and Mental health, Inhibition, Psychological, Young Adult, Health (social science), Substance-Related Disorders, Public Health, Environmental and Occupational Health, Medicine (miscellaneous), Humans, Cognitive Dysfunction, Self Report, Anxiety Disorders
Abstract

Background Impairments in neurocognitive functioning are associated with substance use behavior. Previous studies in neurocognitive predictors of substance use typically use self-report measures rather than neuropsychological performance measures and suffer from low sample sizes and use of clinical diagnostic cut offs. Methods Crossectional data from the HUNT4 Study (Helseundersøkelsen i Trøndelag) was used to study executive neuropsychological performance and self-reported measures of neurocognitive function associated with a history of illicit substance use in a general population sample of young adults in Norway. We performed both between group comparisons and logistic regression modeling and controlled for mental health symptomatology. Results Subjects in our cohort with a self-reported use of illicit substances had significantly higher self-reported mental health and neurocognitive symptom load. A logistic regression model with substance use as response included sex, commission errors and self-reported inattentiveness and anxiety as significant predictors. After 10-fold cross-validation this model achieved a moderate area under the receiver-operator curve of 0.63. To handle the class imbalance typically found in such population data, we also calculated balanced accuracy with a optimal model cut off of 0.234 with a sensitivity of 0.50 and specificity of 0.76 as well as precision recall—area under the curve of 0.28. Conclusions Subtle cognitive dysfunction differentiates subjects with and without a history of illicit substance use. Neurocognitive factors outperformed the effects of depressive symptoms on substance use behavior in this cohort. We highlight the need for using adequate statistical tools for evaluating the performance of models in unbalanced datasets.

Published
2022

21. [Multiple sclerosis : a neurological dysimmune inflammatory disease]

Author

D, Dive, S, Dauby, E, Lommers, I, Hansen, D, Groenendyck, C, Ernon, and P, Maquet

Subjects
Multiple Sclerosis, Disease Progression, Humans, Magnetic Resonance Imaging
Abstract

Multiple sclerosis is a central nervous system autoimmune disease of the white and grey matters. Its pathophysiology is much better well known. It results from the interaction between genetic and environmental susceptibility factors. The role of EBV virus has recently been highlighted. Imaging techniques and neuropathology knowledge allow to distinguish several distinct processes responsible for focal and more diffuse inflammation. Therapeutic advances in recent years have been considerable. Different molecules and treatment sequences can be proposed to the patient with a demonstrated positive impact on the risk of disability secondary progression. Precise follow-up is a key. It requires optimal and early use of various treatments. The therapeutic choice must be guided by obtaining stabilization of the disease, both clinically and in terms of imaging, without exposing the patient to an excessive risk of side effects. Continuous and sequential treatments are available.: La sclérose en plaques est une maladie auto-immune du système nerveux central qui concerne la substance blanche mais aussi la substance grise. Sa physiopathologie est beaucoup mieux connue. Elle résulte de l’interaction entre des facteurs génétiques de susceptibilité et environnementaux. Le rôle du virus EBV a été récemment souligné. Les techniques d’imagerie et les connaissances de neuropathologie ont permis de distinguer plusieurs processus distincts responsables d’une inflammation focale, mais également plus diffuse. Les progrès thérapeutiques des dernières années sont considérables. Différentes molécules et séquences de traitements peuvent être proposées au patient avec un impact positif démontré sur le risque de progression secondaire du handicap. La précision du suivi est un élément clé de la prise en charge. Elle requiert une utilisation optimale, et surtout précoce, des différents traitements. Le choix thérapeutique doit être guidé par l’obtention d’une stabilisation de la maladie, tant sur le plan clinique qu’en imagerie, sans exposer le patient à un risque excessif d’effets secondaires négatifs. Des traitements continus et séquentiels sont disponibles.

Published
2022

22. Group B Streptococcus Infection in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years

Author

Karen M Puopolo, Sagori Mukhopadhyay, Nellie I Hansen, Dustin D Flannery, Rachel G Greenberg, Pablo J Sanchez, Edward F Bell, Sara B DeMauro, Myra H Wyckoff, Eric C Eichenwald, and Barbara J Stoll

Subjects
Microbiology (medical), Adult, Incidence, Infant, Newborn, Infant, Streptococcus agalactiae, Cohort Studies, Young Adult, Infectious Diseases, Child, Preschool, Infant, Extremely Premature, Streptococcal Infections, Major Article, Humans
Abstract

Background This study was performed to determine the incidence of group B Streptococcus (GBS) disease among extremely preterm infants and assess to risk of death or neurodevelopmental impairment (NDI) at a corrected age of 18–26 months. Methods In this observational cohort study of infants enrolled in a multicenter registry, the incidence of GBS disease was assessed in infants born in 1998–2016 at 22–28 weeks’ gestation and surviving for >12 hours. The composite outcome, death or NDI, was assessed in infants born in 1998–2014 at 22–26 weeks’ gestation. Infection was defined as GBS isolation in blood or cerebrospinal fluid culture at ≤72 hours (early-onset disease [EOD]) or >72 hours (late-onset disease [LOD]) after birth. Using Poisson regression models, the outcome was compared in infants with GBS disease, infants infected with other pathogens, and uninfected infants. Results The incidence of GBS EOD (2.70/1000 births [95% confidence interval (CI), 2.15–3.36]) and LOD (8.47/1000 infants [7.45–9.59]) did not change significantly over time. The adjusted relative risk of death/NDI was higher among infants with GBS EOD than in those with other infections (adjusted relative risk, 1.22 [95% CI, 1.02–1.45]) and uninfected infants (1.44 [1.23–1.69]). Risk of death/NDI did not differ between infants with GBS LOD and comparator groups. GBS LOD occurred at a significantly later age than non-GBS late-onset infection. Among infants surviving >30 days, the risk of death was higher with GBS LOD (adjusted relative risk, 1.90 [95% CI, 1.36–2.67]), compared with uninfected infants. Conclusions In a cohort of extremely preterm infants, the incidence of GBS disease did not change during the study period. The increased risk of death or NDI with GBS EOD, and of death among some infants with GBS LOD, supports the need for novel preventive strategies for disease reduction. Clinical Trials Registration NCT00063063.

Published
2022

23. Potential missed opportunities for antenatal corticosteroid exposure and outcomes among periviable births: observational cohort study

Author

Colm P, Travers, Nellie I, Hansen, Abhik, Das, Matthew A, Rysavy, Edward F, Bell, Namasivayam, Ambalavanan, Myriam, Peralta-Carcelen, Alan T, Tita, Krisa P, Van Meurs, and Waldemar A, Carlo

Subjects
Obstetrics and Gynecology
Abstract

Test the hypothesis potential missed opportunities for antenatal corticosteroids increase as gestational age decreases and are associated with adverse outcomes.Observational cohort study.24 US centers in the Neonatal Research Network.Actively treated infants 22-25 weeks' gestation and birth weight 401-1000 grams, without major birth defects, born 2006-2018.Potential missed opportunity was defined as no antenatal corticosteroids but did have prenatal antibiotics, and/or magnesium sulfate, and/or prolonged rupture of membranes. Poisson regression models adjusted for baseline characteristics.Antenatal corticosteroid exposure, mortality, and severe intracranial hemorrhage or periventricular leukomalacia.6966 (87.5%) were exposed to antenatal corticosteroids, 454 (5.7%) had no exposure but potential missed opportunities for antenatal corticosteroid exposure, and 537 (6.7%) had no exposure and no evidence of potential missed opportunities. Compared with infants born at 25 weeks, potential missed opportunities for antenatal corticosteroid exposure were more likely at 22 weeks (adjusted relative risk (aRR) [95% CI] 11.06 [7.52-16.27]) and 23 weeks (3.24 [2.44-4.29]) but did not differ at 24 weeks (1.08 [0.82-1.42]). Potential missed opportunities for antenatal corticosteroids decreased over time at 22-23 weeks' gestation. Antenatal corticosteroid exposed infants had lower risk of death (31.0% vs 54.8%; 0.77 [0.70-0.84]) and survivors had lower risk of severe brain injury (25.0% v 44.5%; 0.64 [0.55-0.73]) compared with infants with potential missed opportunities.Potential missed opportunities for antenatal corticosteroid exposure increased with decreasing gestational age and were associated with higher rates of death and severe brain injury among actively treated periviable births.

Published
2022

24. Long-Term Comparison of 7 SARS-CoV-2 Antibody Assays in the North Zealand Covid-19 Cohort

Author

Elias F Wiwe, Elin R Carlsson, Christina L Rasmussen, Pernille Rasmussen, Robert Ougaard, Steen I Hansen, Thomas Schiøler, Søren Kristiansen, Young B Hansen, and Thore Hillig

Subjects
SARS-CoV-2 antibodies, SARS-CoV-2, comparison study, longitudinal study, COVID-19, General Medicine, cohort, Antibodies, Viral, serological testing, COVID-19 Serological Testing, immunoassays, Immunoglobulin G, Humans, Covid-19
Abstract

Background Throughout the coronavirus disease 2019 (Covid-19) pandemic numerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody assays have been approved through Emergency Use Authorization and require further evaluation of sensitivity and specificity in clinical laboratory settings prior to implementation. Methods We included 1733 samples from 375 PCR-confirmed SARS-CoV-2–positive individuals of the North Zealand Covid-19 Cohort in an 8-month period. We investigated diagnostic sensitivity and specificity against consensus and PCR and interassay agreement over time for 5 SARS-CoV-2 immunoassays [Roche-nucleocapsid (NC)-total, Roche-receptor binding domain (RBD)-total, Siemens-RBD-IgG, Siemens-RBD-total, Thermo Fisher Scientific (TFS)-RBD-IgG] commercially available on automated platforms and 2 ELISA assays (TFS-RBD-total, Wantai-RBD-total). Results Early interassay discrepancy in up to 49% of samples decreased steadily during the first 18 days. By day 18, all assays had reached a plateau between 82.3% and 90.5% seropositivity compared to PCR. Assays ranked by closest agreement with the consensus model beyond day 18 (sensitivity/specificity against consensus) were as follows: Roche-RBD-total, 99.8%/100.0%; Wantai-RBD-total, 99.8%/99.7%; Roche-NC-total, 97.8%/100.0%; Siemens-RBD-total, 98.0%/98.7%; TFS-RBD-total, 96.9%/99.7%; TFS-RBD-IgG, 91.5%/100.0%; and Siemens-RBD-IgG, 94.6%/89.9%. We found that 7.8% of PCR-positive patients remained seronegative in all assays throughout the study. Conclusions All included assays had sensitivities against consensus >90% past day 18. For the current recommended use of antibody assays to detect former, undocumented Covid-19, our data suggest the use of total antibody assays rather than IgG-specific assays due to higher long-term sensitivity. Finally, a nonresponding subpopulation of 7.8% in our cohort with persistent seronegative results raises concern of a possible substantial number of people with continued low protection following natural SARS-CoV-2 infection.

Published
2021
Full Text
View/download PDF

25. AB0584 MANAGEMENT OF REFERRALS, TREATMENT STRATEGY, AND RESEARCH CHALLENGES IN POLYMYALGIA RHEUMATICA AMONGST RHEUMATOLOGISTS WORLDWIDE: A QUESTIONNAIRE BASED STUDY

Author

A. Overgaard Donskov, S. Mackie, E. M. Hauge, C. Toro Gutiérrez, I. Hansen, A. Hemmig, A. Van der Maas, T. A. Gheita, B. Dalsgaard Nielsen, K. Douglas, R. Conway, E. Rezus, B. Dasgupta, S. Monti, E. Matteson, S. E. Sattui, M. Matza, V. Ocampo, A. Bran, S. Appenzeller, A. Goecke, N. Colman MC Leod, H. Keen, M. Kuwana, L. Gupta, B. Salim, G. Harifi, M. Erraoui, N. Ziade, N. A. Al-Ani, A. Ajibade, J. Knitza, L. Frølund, M. Yates, V. Pimentel-Quiroz, A. Lyrio, M. Sandovici, K. Van der Geest, T. Helliwell, E. Brouwer, C. Dejaco, and K. Keller

Subjects
Rheumatology, Immunology, Immunology and Allergy, General Biochemistry, Genetics and Molecular Biology
Abstract

BackgroundPolymyalgia rheumatica (PMR) is diagnosed and treated by both general practitioners (GP) and rheumatologists. How rheumatologists around the world manage the referral process of patients with PMR from GP’s has not been described. EULAR/ACR guidelines recommend initial prednisolone doses between 12.5 and 25 mg, but it is unknown if guidelines are followed in daily clinical practice1. In addition, the understanding of challenges for recruitment to clinical trials in PMR is currently limited.ObjectivesThis study aims to describe the management of referrals, treatment strategy, and recruitment to clinical trials in PMR among rheumatologists worldwide.MethodsAn English language questionnaire was drafted by a working group of rheumatologists and GP’s from 6 different countries. Questions concerned: 1: respondent, 2: referrals, 3: prednisolone, and 4: barriers to research. Questionnaires were distributed to rheumatologists via members of the International PMR/GCA study group. Answers were collected via an online survey tool (Redcap), from 2nd of November 2021 to 27th of January 2022. Countries were grouped by income and geographical region based on the World bank classifications. Data were weighted by number of inhabitants in a country, based on the United Nations age specific population count, divided by number of respondents in a country. Countries with more than 20 respondents were included.ResultsResults from 27 countries were analysed including 1000 responders in total (Figure 1). There was large variation in time from referral to first assessment, initial dose of prednisolone was high, duration of treatment was relatively short, and a large proportion of patients with newly diagnosed PMR received prednisolone prior to rheumatological evaluation (Table 1). Concerning the 15% of respondents who performed research in PMR, 52% had participated in clinical trials and 56% of the responders experienced difficulties with recruitment.Table 1.Characteristics of reponders, referrals, and treatment.Geographical regionIncomeThe worldEurope and Central AsiaNorth AmericaLatin AmericaEast Asia and PacificSouth AsiaMiddle East and AfricaHigh- income countriesLow- and middle- income countriesRespondersResponders (n), Completed questionnaire (total)875 (1000)294 (304)78 (81)136 (152)53 (53)53 (72)261 (338)446 (458)429 (542)Experience as rheumatologist (years)11 (6-20)12 (6-20)7 (4-20)11 (6-23)21 (10-30)7 (4-10)9 (5-18)11 (5-22)8 (5-12)ReferralsGP’s can discuss patients prior to referral, %647979575860677461Referred patients seen (%)100 (90-100)100 (90-100)100 (100-100)100 (100-100)100 (95-100)100 (100-100)100 (60-100)100 (100-100)100 (90-100)Evaluation > 2 weeks after referral, %26498060216185815PrednisoloneStarted prior to rheumatological evaluation (%)50 (20-50)60 (30-80)70 (50-80)50 (10-50)30 (20-50)50 (20-80)20 (0-50)50 (30-80)50 (10-70)Initial dose (mg)20 (15-40)20 (15-20)20 (15-20)20 (20-40)15 (15-15)20 (15-40)20 (15-40)15 (15-20)20 (15-40)Initial dose > 25 mg, %32964104143642Duration of treatment (months)12 (6-12)12 (12-18)12 (10-18)6 (3-12)18 (12-18)12 (6-12)6 (3-12)12 (12-18)9 (6-12)Data presented as weighted median (interquartile range) unless otherwise stated.GP: general practitionerConclusionThis is the first description of current practice in managing referrals and treatment of PMR by rheumatologists worldwide. In general, median treatment duration was according to EULAR/ACR guidelines, but initial dose of prednisolone was often higher than recommended in many parts of the world. PMR patients were often seen more than two weeks after referral, and treatment had started prior to first rheumatological evaluation.References[1]Dejaco C, Singh YP, Perel P, et al. 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Annals of the rheumatic diseases 2015; 74(10): 1799-807.AcknowledgementsThis study was endorsed by the international PMR/GCA study group.Disclosure of InterestsAgnete Overgaard Donskov: None declared, Sarah Mackie: None declared, Ellen-Margrethe Hauge Speakers bureau: AbbVie, Sanofi, Sobi, MSD, UCB, Consultant of: AbbVie, Sanofi, Sobi, MSD, UCB, Grant/research support from: Novo Nordic Foundation, Danish Rheumatism Association, Danish Regions Medicine Grants, Roche, Novartis, Celgene, MSD, Pfizer, Roche, Sobi, CARLOS TORO GUTIÉRREZ: None declared, Ib Hansen: None declared, Andrea Hemmig: None declared, Aatke van der Maas: None declared, Tamer A Gheita: None declared, Berit Dalsgaard NIelsen Paid instructor for: Roche, Karen Douglas: None declared, Richard Conway Speakers bureau: Janssen, Roche, Sanofi, Abbvie,, Elena Rezus: None declared, Bhaskar Dasgupta: None declared, Sara Monti: None declared, Eric Matteson Consultant of: Boehringer-Ingelheim,, Grant/research support from: Boehringer Ingelheim,, Sebastian E. Sattui Grant/research support from: AstraZeneca, Mark Matza: None declared, Vanessa Ocampo Speakers bureau: Abbvie, Andrea Bran: None declared, Simone Appenzeller Grant/research support from: GSK, Annelise Goecke Speakers bureau: Abbvie, Boehringer Ingelheim, Recalcine. Consultant Abbvie, Boehringer Ingelheim, NELLY COLMAN MC LEOD Speakers bureau: Laboratorios FAPASA (Farmacéutica Paraguay), Helen Keen Speakers bureau: Roche, Abbvie, Masataka Kuwana: None declared, Latika Gupta: None declared, Babur Salim: None declared, Ghita Harifi Speakers bureau: Abvie, Johnson and johnson, Lilly, Novartis, Mariama Erraoui: None declared, Nelly Ziade Speakers bureau: Abbvie, Eli Lilly, Janssen, Pfizer, Pierre Fabre, Roche, Novartis, Sanofi-Aventis, Paid instructor for: Abbvie, Eli Lilly, Sanofi-Aventis, Pfizer, Janssen, Novartis., Consultant of: Abbvie, Eli Lilly, Janssen, Pfizer, Roche, Novartis, Sandoz, Grant/research support from: Abbvie, Celgene - Algorithm, Bristol-Myers Squibb - NewBridge, Pfizer, Nizar Abdulateef Al-Ani: None declared, Adeola Ajibade: None declared, Johannes Knitza: None declared, Line Frølund: None declared, Max Yates: None declared, Victor Pimentel-Quiroz: None declared, Andre Lyrio: None declared, Maria Sandovici: None declared, Kornelis van der Geest Speakers bureau: Roche, Toby Helliwell Grant/research support from: Valneva, Elisabeth Brouwer Speakers bureau: Roche, Christian Dejaco Speakers bureau: Abbvie, Eli Lilly, Janssen, Novartis, Pfizer, Roche, Galapagos and Sanofi, Consultant of: Abbvie, Eli Lilly, Janssen, Roche, Galapagos and Sanofi, Kresten Keller: None declared

Published
2022
Full Text
View/download PDF

26. Organelle Genome Variation in the Red Algal Genus Ahnfeltia (Florideophyceae)

Author

Danilo E. Bustamante, Christine A. Maggs, Gayle I. Hansen, Hocheol Kim, Martha S. Calderon, Ji Hyun Yang, Andrés Mansilla, and Hwan Su Yoon

Subjects
Genetic diversity, Phylogenetic tree, phylogeograhy, Ahnfeltia, Pseudogene, genome architecture variation, genetic diversity, Biology, QH426-470, biology.organism_classification, Genome, Monophyly, Evolutionary biology, mitochondrial genome, Genetics, plastid genome, Molecular Medicine, ORFS, Genome size, Genetics (clinical)
Abstract

The agarophyte Ahnfeltia (Ahnfeltiales, Rhodophyta) is a globally widespread genus with 11 accepted species names. Two of the most widespread species in this genus, A. plicata and A. fastigiata, may have diverged genetically due to past geographic changes and subsequent geographic isolation. To investigate this genomic and genetic diversity, we generated new plastid (ptDNAs) and mitochondrial genomes (mtDNAs) of these Ahnfeltia species from four different regions (A. plicata - Chile and UK and A. fastigiata - Korea and Oregon). Two architecture variations were found in the Ahnfeltia genomes: in ptDNA of A. fastigiata Oregon, the hypothetical pseudogene region was translocated, likely due to recombination with palindromic repeats or a gene transfer from a red algal plasmid. In mtDNA of A. fastigiata Korea, the composition of the group II intronic ORFs was distinct from others suggesting different scenarios of gain and loss of group II intronic ORFs. These features resulted in genome size differences between the two species. Overall gene contents of organelle genomes of Ahnfeltia were conserved. Phylogenetic analysis using concatenated genes from ptDNAs and mtDNAs supported the monophyly of the Ahnfeltiophycidae. The most probable individual gene trees showed that the Ahnfeltia populations were genetically diversified. These trees, the cox1 haplotype network, and a dN/dS analysis all supported the theory that these Ahnfeltia populations have diversified genetically in accordance with geographic distribution.

Published
2021
Full Text
View/download PDF

27. 5 Years of Exercise Intervention Did Not Benefit Cognition Compared to the Physical Activity Guidelines in Older Adults, but Higher Cardiorespiratory Fitness Did. A Generation 100 Substudy

Author

Daniel R. Sokołowski, Tor I. Hansen, Henning H. Rise, Line S. Reitlo, Ulrik Wisløff, Dorthe Stensvold, and Asta K. Håberg

Subjects
Aging, medicine.medical_specialty, Cognitive Neuroscience, Physical fitness, neuropsychology, recall, Neurosciences. Biological psychiatry. Neuropsychiatry, seniors, Interval training, memory, prevention, Medicine, Aerobic exercise, Effects of sleep deprivation on cognitive performance, Cognitive decline, Original Research, business.industry, cognitive aging, Cardiorespiratory fitness, Cognition, Physical therapy, executive abilities, Verbal memory, aerobic training, business, RC321-571, Neuroscience
Abstract

Background: Aerobic exercise is proposed to attenuate cognitive decline in aging. We investigated the effect of different aerobic exercise interventions and cardiorespiratory fitness (CRF) upon cognition throughout a 5-year exercise intervention in older adults.Methods: 106 older adults (52 women, age 70-77 years) were randomized into high-intensity interval training (HIIT; ∼90% peak heart rate), moderate-intensity continuous training (MICT; ∼70% peak heart rate), or control for 5 years. The HIIT and MICT groups performed supervised training twice weekly, while the control group was asked to follow the national physical activity guidelines (30 min of physical activity/day). At baseline, 1-, 3-, and 5-year follow-up, participants partook in cognitive testing (spatial memory, verbal memory, pattern separation, processing speed, working memory, and planning ability), underwent clinical testing, and filled out health-related questionnaires. Linear mixed models were used to assess the effects of the exercise group and CRF (measured as peak and max oxygen uptake) on each cognitive test. The effects of changes in CRF on changes in each cognitive test score throughout the intervention were also assessed. The associations between baseline CRF and cognitive abilities at the follow-ups were investigated using linear regressions.Results: There was no group-by-time interaction on the cognitive measures, and neither HIIT nor MICT participation was associated with better cognitive performance than control at any time point during the 5-year intervention. All groups increased their CRF similarly during the 1st year and subsequently declined back to baseline levels after 5 years. A higher CRF was associated with higher processing speed throughout the intervention while increasing CRF during the intervention was associated with better working memory and worse pattern separation. Higher CRF at baseline predicted consistently better processing speed and verbal memory performance.Conclusion: In this first 5-year randomized controlled trial investigating the effects of HIIT, MICT, and physical activity according to national guidelines on cognition, we observed no effect of exercise intervention group on cognition when compared to following the national physical activity guidelines. Still, the results showed that higher CRF and increasing CRF benefited multiple, but not all, cognitive abilities in older adults.Clinical Trial Registration:www.ClinicalTrials.gov, identifier [NCT01666340].

Published
2021

29. Prolonged duration of early antibiotic therapy in extremely premature infants

Author

Abhik Das, P. Brian Smith, Rosemary D. Higgins, C. Michael Cotten, Karen M. Puopolo, Pablo J. Sánchez, Dhuly Chowdhury, Rachel G. Greenberg, Barbara J. Stoll, Sagori Mukhopadhyay, and Nellie I. Hansen

Subjects
2. Zero hunger, Extremely premature, Pediatrics, medicine.medical_specialty, medicine.drug_class, business.industry, Birth weight, Antibiotics, Retrospective cohort study, Odds ratio, Child health, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, 030225 pediatrics, Antibiotic therapy, Pediatrics, Perinatology and Child Health, medicine, Gestation, business, 030217 neurology & neurosurgery
Abstract

Author(s): Greenberg, Rachel G; Chowdhury, Dhuly; Hansen, Nellie I; Smith, P Brian; Stoll, Barbara J; Sanchez, Pablo J; Das, Abhik; Puopolo, Karen M; Mukhopadhyay, Sagori; Higgins, Rosemary D; Cotten, C Michael; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network | Abstract: BackgroundProlonged early antibiotics in extremely premature infants may have negative effects. We aimed to assess prevalence and outcomes of provision of prolonged early antibiotics to extremely premature infants in the absence of culture-confirmed infection or NEC.MethodsCohort study of infants from 13 centers born without a major birth defect from 2008-2014 who were 401-1000 grams birth weight, 22-28 weeks gestation, and survived ≥5 days without culture-confirmed infection, NEC, or spontaneous intestinal perforation. We determined the proportion of infants who received prolonged early antibiotics, defined as ≥5 days of antibiotic therapy started at ≤72 h of age, by center and over time. Associations between prolonged early antibiotics and adverse outcomes were assessed using multivariable logistic regression.ResultsA total of 5730 infants were included. The proportion of infants receiving prolonged early antibiotics varied from 30-69% among centers and declined from 49% in 2008 to 35% in 2014. Prolonged early antibiotics was not significantly associated with death (adjusted odds ratio 1.17 [95% CI: 0.99-1.40], p = 0.07) and was not associated with NEC.ConclusionsThe proportion of extremely premature infants receiving prolonged early antibiotics decreased, but significant center variation persists. Prolonged early antibiotics were not significantly associated with increased odds of death or NEC.

Published
2019
Full Text
View/download PDF

30. Organelle Genome Variation in the Red Algal Genus

Author

Hocheol, Kim, Ji Hyun, Yang, Danilo E, Bustamante, Martha S, Calderon, Andres, Mansilla, Christine A, Maggs, Gayle I, Hansen, and Hwan Su, Yoon

Subjects
mitochondrial genome, phylogeograhy, Ahnfeltia, Genetics, plastid genome, genome architecture variation, genetic diversity, Original Research
Abstract

The agarophyte Ahnfeltia (Ahnfeltiales, Rhodophyta) is a globally widespread genus with 11 accepted species names. Two of the most widespread species in this genus, A. plicata and A. fastigiata, may have diverged genetically due to past geographic changes and subsequent geographic isolation. To investigate this genomic and genetic diversity, we generated new plastid (ptDNAs) and mitochondrial genomes (mtDNAs) of these Ahnfeltia species from four different regions (A. plicata - Chile and UK and A. fastigiata - Korea and Oregon). Two architecture variations were found in the Ahnfeltia genomes: in ptDNA of A. fastigiata Oregon, the hypothetical pseudogene region was translocated, likely due to recombination with palindromic repeats or a gene transfer from a red algal plasmid. In mtDNA of A. fastigiata Korea, the composition of the group II intronic ORFs was distinct from others suggesting different scenarios of gain and loss of group II intronic ORFs. These features resulted in genome size differences between the two species. Overall gene contents of organelle genomes of Ahnfeltia were conserved. Phylogenetic analysis using concatenated genes from ptDNAs and mtDNAs supported the monophyly of the Ahnfeltiophycidae. The most probable individual gene trees showed that the Ahnfeltia populations were genetically diversified. These trees, the cox1 haplotype network, and a dN/dS analysis all supported the theory that these Ahnfeltia populations have diversified genetically in accordance with geographic distribution.

Published
2021

32. Measurement of b jet shapes in proton-proton collisions at √s = 5.02 TeV

Author

Navid Rad, Brian L Winer, Mehmet Özgür Sahin, Donato Creanza, Marc Dobson, Heiner Tholen, Yagya Raj Joshi, Y-J Lee, Alexander Spiridonov, Francesca Nessi-Tedaldi, Matti J Kortelainen, Cheng-Chieh Peng, Susan Gascon, Umberto Dosselli, M. Gola, J. Taylor, T. Boccali, Riccardo Salvatico, Maurizio Pierini, David Cussans, Yongho Jeong, Jack King, R. Vidal, Gunther Roland, K. El Morabit, Ji Hwan Bhyun, Andreas Werner Jung, Chandiprasad Kar, Paraskevas Gianneios, R. E. Sosa Ricardo, Oliver Pooth, A. García Alonso, Anadi Canepa, Jan Steggemann, Fiorenza Micheli, Andrés Cabrera, Illia Khvastunov, E. A. De Wolf, Dario Menasce, Yuta Takahashi, Lea Caminada, Rong-Shyang Lu, Andrea Perrotta, R. Di Maria, Guillaume Bourgatte, Fanbo Meng, Caroline Collard, Georgios Anagnostou, Melody A. Swartz, Maxwell Chertok, Kristian Harder, Simranjit Singh Chhibra, Ali Eren Simsek, Eric Conte, David Barney, Aleksandra Lelek, Andreas Hinzmann, Dipak Kumar Mishra, J. A. Brochero Cifuentes, Simone Bologna, J. G. Branson, Georg Steinbrück, C. Oropeza Barrera, Sioni Summers, Mikko Voutilainen, Sumit Keshri, Mohsen Naseri, Simon Regnard, Fuqiang Wang, Stephanie Beauceron, Sergey Polikarpov, Justin Pilot, Petr Moisenz, David Ja Cockerill, Wolfgang Lange, Marcin Konecki, Artur Lobanov, Danek Kotlinski, Jordan Martins, A. Melo, Denis Gelé, Catherine Schiber, Mauro Emanuele Dinardo, Carmen Albajar, Sven Dildick, Nhan Viet Tran, Mohammad Abrar Wadud, Christof Roland, Ulrich Husemann, A. Manousakis-Katsikakis, Fabio Monti, Nathaniel Pastika, Kyle Tos, Ioannis Evangelou, C. K. Mackay, Barbara Clerbaux, Lisa Borgonovi, Neil Schroeder, Irene Zoi, Marcello Maggi, Davide Piccolo, Jiajing Mao, Leonid Levchuk, Erik Gottschalk, Andrea Delgado, Duncan Leggat, S. Kaplan, Joscha Knolle, Luca Scodellaro, A. A. Bin Anuar, Thorben Quast, Seth Cooper, W. Snoeys, Michael Benjamin Andrews, Simone Paoletti, Christos Roskas, Atanu Modak, Cristina Tuve, R. G. Kellogg, Alexander Pauls, Damir Lelas, Giorgia Rauco, Nancy Marinelli, Abhijith Gandrakota, Suchandra Dutta, Maria Cepeda, Jorgen D'Hondt, Wolfgang Funk, Tengizi Toriashvili, Rizki Syarif, David Colling, Amina Zghiche, Emily MacDonald, Danilo Meuser, Andrew Gilbert, Dajeong Jeon, Subash Chandra Behera, Borislav Pavlov, Vladimir Karjavine, Csaba Hajdu, Emyr Clement, C. Fallon, J. A. Murillo Quijada, Giulio Mandorli, Daniela Schäfer, T. Mitchell, Bahareh Roozbahani, James Hirschauer, Christopher Brainerd, Ibrahim Soner Zorbakir, Giacomo Sguazzoni, Javier Duarte, Mario Masciovecchio, Huilin Qu, Semra Turkcapar, Linda Finco, A. De Cosa, Hannes Sakulin, Ia Iashvili, Roberto Seidita, Jean-Roch Vlimant, Brajesh C Choudhary, Paul David Luckey, F. Mohamad Idris, Sébastien Viret, Marco Cipriani, Peter Elmer, Jean-Baptiste Sauvan, Malte Backhaus, Anne-Marie Magnan, Wagner Carvalho, Oksana Bychkova, James Letts, Nadeesha Wickramage, Anna Zanetti, Q. Ingram, Mingshui Chen, L. Valencia Palomo, Ridhi Chawla, Meenakshi Narain, Mirena Ivova Paneva, Thomas Eichhorn, Alessandro Thea, David Vannerom, Plamen Iaydjiev, Marcella Diemoz, M. Flechl, Gigi Rolandi, G. Cucciati, Wei Li, Thomas Schuh, Stefano Argiro, Zhenbin Wu, Bhawna Gomber, Marcello Mannelli, Christian Schwanenberger, Francesco Brivio, Jordan Nash, Sung Keun Park, Greg Landsberg, Cécile Caillol, Sw. Banerjee, Manjit Kaur, Salvatore Buontempo, Paul Avery, Salavat Abdullin, Lisa Benato, L. I. Estevez Banos, Quentin Python, Randy Ruchti, Joe Incandela, Luca Cadamuro, Matthias Komm, Arnab Purohit, Wei Zhang, Simona Cometti, Scott Thomas, Tilman Rohe, Sara Nabili, M. Bluj, Nicholas Wardle, Tao Huang, Andris Skuja, Davide Zuolo, Ivica Puljak, Hans Reithler, Colin Jessop, Ben Bylsma, Giuseppe Iaselli, Alessandro Calandri, M. Calderon De La Barca Sanchez, Mia Tosi, L. Romero, Roberto Tenchini, Cameron Bravo, Meng Xiao, Jacobo Konigsberg, Bryan Cardwell, Isabel Pedraza, Paolo Azzurri, Emilien Chapon, Vittorio Raoul Tavolaro, Y. Musienko, B. McMaster, M. C. Fouz, Samuel Boren, L. V. Kardapoltsev, Sridhara Dasu, Emilio Meschi, W. T. Lin, Dylan Hsu, Raman Khurana, Anna Colaleo, Yildiray Komurcu, Matthias Kasemann, Mykola Savitskyi, Alexandros Attikis, Cole Lindsey, Paola Salvini, Valeria Botta, M. De Palma, V. Monaco, Georgi Sultanov, Bradley Cox, Evan Wolfe, David Cutts, Kevin Stenson, C. Mora Herrera, Achim Stahl, Amitabh Lath, Simon Kudella, Fan Xia, Dietrich Liko, Mykhailo Dalchenko, S. W. Lee, Laura Dodd, Andrew Levin, Anton Stepennov, Suat Ozkorucuklu, Wei Xie, Rainer Wallny, V. Drugakov, E. Ayala, Wajid Ali Khan, J. M. Vizan Garcia, Bugra Bilin, J. L. Dulemba, M. Fernandez, Shaaban Khalil, Tamás Álmos Vámi, Florian Beaudette, Daniel Arcaro, Marek Walczak, Andrea Gelmi, L. Viliani, Troy Mulholland, Seungkyu Ha, S. Y. Hoh, Angela Mehta, J. D. Richman, Yannik Rath, Predrag Cirkovic, Rachel Yohay, J. K. Lim, Prashant Shukla, R. Loveless, André Rosowsky, Andrew Ivanov, Byung-Sik Hong, Michael Hildreth, M. S. Meyer, Bora Akgun, Luigi Guiducci, Gregory R Snow, Igor Volobouev, Özlem Özçelik, F. L. Fabbri, Daniele Fasanella, D. Green, Anup Kumar Sikdar, F. Simonetto, Andrew Loeliger, Andrey Gribushin, Ashley Parker, H. El Mamouni, Valerie Scheurer, Marius Preuten, Nils Faltermann, Duong Nguyen, Vladyslav Danilov, Kati Lassila-Perini, Petra Merkel, De Hua Zhu, S. Somalwar, I. O. Atakisi, Vladimir Popov, D. H. Miller, C. Martinez Rivero, A. Kasem, Viola Sordini, Marek Gruchala, Jingyu Luo, Si Xie, Pedrame Bargassa, Jacopo Pazzini, Erika Garutti, Giorgio Apollinari, David Yu, Ulf Behrens, Sema Zahid, Sergei Gleyzer, Ana Ovcharova, Gyorgy Bencze, M. A. Shah, Tai Sakuma, Dimitri Bourilkov, Alexandre Belloni, Giancarlo Mantovani, Carlo Battilana, Sergio P Ratti, Andrea Venturi, M. Khakzad, Rino Castaldi, Simone Scarfi, Anterpreet Kaur, Alibordi Muhammad, Artur Kalinowski, Frank Chlebana, Yutaro Iiyama, Mehmet Kaya, Intae Yu, Kuntal Mondal, Inna Kucher, Jelena Mijuskovic, B. Singh, M. Mohammadi Najafabadi, Charles Harrington, Emil Sørensen Bols, Panja-Riina Luukka, Giovanni Organtini, Roberto Salerno, Scarlet Norberg, Piero Giorgio Verdini, Ivan Amos Cali, A. Carvalho Antunes De Oliveira, Pallavi Bhat, Filippo Errico, Deepak Kumar Sahoo, Weinan Si, Philipp Millet, Brian Dorney, Nabin Poudyal, Sharon Hagopian, Ralf Ulrich, Juliette Alimena, Paul Asmuss, E. J. Tonelli Manganote, Ekaterina Kuznetsova, Lloyd Stanley Durkin, Gobinda Majumder, Alain Givernaud, H. Rejeb Sfar, Tanmay Sarkar, Matthew Joyce, Anastasia Karavdina, T. W. Wang, Robert Stone, R. Taus, Nikolay Voytishin, K. H. M. Kwok, Kira Burt, Zehui Zhang, Eleni Erodotou, Brian Francis, Tamas Ferenc Csorgo, Benjamin Mesic, S. W. Cho, Andrew Whitbeck, Viktor Veszpremi, F. Pandolfi, Guido Tonelli, Mariarosaria D'Alfonso, Mario Galanti, Andreas Psallidas, C. Vander Velde, R. Bhattacharya, E. Carrera Jarrin, Douglas Wright, Matej Roguljic, Sezen Sekmen, Olga Kodolova, Ram Krishna Dewanjee, Bora Isildak, Z. Liu, Teruki Kamon, Robert M Harris, G. Correia Silva, Elliot Hughes, Zoltan Szillasi, Jussi Viinikainen, P. D. Dauncey, Prafulla Kumar Behera, Riccardo Andrea Manzoni, Christian Veelken, Nicholas Manganelli, Alessia Saggio, Kinga Anna Wozniak, Norbert Neumeister, Jane Nachtman, Sergio F Novaes, Samet Lezki, David Petyt, J. D. Lewis, Benjamin Charles Radburn-Smith, Yu. Andreev, Edoardo Bossini, Markus Klute, W. Van Doninck, Kevin Nash, Thea Klaeboe Aarrestad, F. Rezaei Hosseinabadi, Gurpreet Singh Chahal, A. Baden, M. Barrio Luna, Hans Rykaczewski, Andrew Buccilli, Charles C. Richardson, Arun Kumar, Daniele Spiga, Y. J. Mao, Chiara Mariotti, James Buchanan, Maxim Pieters, Inseok Yoon, Zeljko Antunovic, Claudia-Elisabeth Wulz, Andrey Uzunian, Christopher Palmer, Alice Bean, I. Gonzalez Caballero, Shabnam Jabeen, Paolo Spagnolo, P. Gras, A. Di Francesco, W. Ji, Anna Elliott-Peisert, Vuko Brigljevic, Lucia Silvestris, David Taylor, B. Jayatilaka, Vincenzo Innocente, Mattia Lizzo, Claudio Quaranta, Paolo Checchia, Alberto Messineo, John Almond, Aran Garcia-Bellido, Lindsey Gray, Fabio Cossutti, Sabuj Ghosh, Philip Baringer, Enrico Robutti, George Stephans, S. Nandan, A. De Iorio, Pietro Vischia, Giacomo Fedi, Francisco Matorras, John A Coughlan, Daniel Winterbottom, N. Cavallo, Po-Hsun Chen, Balazs Ujvari, Stefano Mersi, Federica Legger, Tuure Tuuva, Morgan Lethuillier, Yasar Onel, Ulrich Heintz, M. Kovac, Bjorn Burkle, Mykyta Haranko, Silvia Maselli, Ioannis Papadopoulos, Efstathios Paganis, R. Frühwirth, Erica Brondolin, K. W. Bell, Nataliia Kovalchuk, Dhanush Anil Hangal, Debarati Roy, Marius Teroerde, Furkan Dolek, Franco Ligabue, J. Alexander, G. M. Bilei, David Jonathan Hofman, Jeremy Mans, Bożena Boimska, Kerem Cankocak, Harrison Prosper, Joachim Mnich, Marta Baselga, V. Smirnov, Mario Deile, Stephen Robert Wagner, Amedeo Staiano, Christoph Paus, Wolfgang Waltenberger, Piergiulio Lenzi, Giles Strong, P. Van Hove, Alice Cocoros, Alexei Raspereza, Christoph Heidecker, A. G. Stahl Leiton, Andrej Saibel, P. Martinez Ruiz del Arbol, Marc Dejardin, Panagiotis Katsoulis, Dan Quach, Nicola Bacchetta, S. Consuegra Rodríguez, K. Osterberg, Maximilian Heindl, Shervin Nourbakhsh, Andreas Mussgiller, Valerio Bertacchi, Fotios Ptochos, Gage Dezoort, C. Ramón Álvarez, Marco Monteno, Ohannes Kamer Köseyan, Joel Goldstein, N. Vanegas Arbelaez, Luciano Ristori, Milena Misheva, Luigi Calligaris, Riccardo Bellan, Camille Camen, Kevin Pedro, Stephen Sanders, Wesley H Smith, Piet Verwilligen, S. Belforte, Nabarun Dev, Johan Borg, Alexey Volkov, A. Escalante Del Valle, Joosep Pata, Stephen Mrenna, Denys Lontkovskyi, Konstantinos Manolopoulos, Silvano Tosi, Ryan Heller, Maxime Guilbaud, Daniel Treille, Kelvin Mei, S. R. Dugad, Salvatore My, T. A. Gómez Espinosa, Alessio Boletti, Jie Zhang, Francesca Romana Cavallo, Ignacio Redondo, Benjamin Stieger, Yurii Maravin, Vladimir Gavrilov, H. Sert, D. E. Pellett, T. Aushev, Thomas Reitenspiess, A. Bermúdez Martínez, Rylan Conway, Kevin Mcdermott, Dmytro Kovalskyi, V. Kutzner, Erhan Gülmez, Kaori Maeshima, Aurelijus Rinkevicius, Martin Erdmann, Min Suk Kim, Vipin Bhatnagar, T. Liu, Alexandre Kaminskiy, Alexis Pompili, Alexander Savin, M. Finger, Viktor Savrin, Mitchell Wayne, Karol Bunkowski, Shubham Pandey, Wei Shi, Andrea Castro, O. Rieger, Thomas Klijnsma, W. S. Hou, Nadezda Chernyavskaya, M. Medina Jaime, Hongbo Liao, Kenneth Long, Andrea Carlo Marini, Gyorgy Vesztergombi, Ali Harb, Frank Jm Geurts, Giovanni Petrucciani, Tom A. Williams, Cristina Mantilla, Nicholas Eminizer, D. Y. Wang, Daniele Ruini, Margaret Zientek, Jan Eysermans, Unki Yang, Gourab Saha, Valentina Dutta, Andrew Wisecarver, K. F. Chen, Georgia Karapostoli, L. Malgeri, Tobias Pook, Kamuran Dilsiz, Seema Bahinipati, Jay Hauser, A. Vilela Pereira, E. Palencia Cortezon, Konstantinos Theofilatos, Sandor Czellar, Ozgun Kara, P. Kontaxakis, Manuel Giffels, Juska Pekkanen, Daniele Pedrini, Benedikt Maier, P. Priyanka, Alexander Tapper, Vyacheslav Krutelyov, Efe Yazgan, Frank Hartmann, Michail Bachtis, Suresh C Tonwar, Sylvie Braibant-Giacomelli, Jeffrey Roskes, Kalliopi Manitara, Luciano Orsini, Luca Pacher, Bennett Marsh, Duncan Carlsmith, Attilio Santocchia, Daniel Gastler, Aleko Khukhunaishvili, Stefano Marcellini, Sonaina Undleeb, Spandan Mondal, A. C. Le Bihan, J. F. de Trocóniz, James Dolen, Salvatore Nuzzo, Freya Blekman, Ilse Krätschmer, David Michael Morse, L. Layer, G. Hamel de Monchenault, Aditee Rane, Peter I. Hansen, Jean Fay, Matthias Ulrich Mozer, Claire Shepherd-Themistocleous, Michael Wassmer, Antonis Agapitos, Tanvi Wamorkar, Patricia McBride, Marc Weinberg, Philippe Bloch, C. De Oliveira Martins, Martina Vit, Sh. Jain, A. Morelos Pineda, Krzysztof Doroba, Laurent Forthomme, Lorenzo Bianchini, D. De Jesus Damiao, Claudio Grandi, Tamas Novak, Evan Ranken, S. B. Oh, Colin Bernet, Paolo Rumerio, Dylan Rankin, Andrew Brinkerhoff, Eshwen Bhal, Lorenzo Uplegger, Alexander Malakhov, Günter Flügge, Ugur Kiminsu, Thomas Ferguson, Rohith Saradhy, Patrick Jarry, Alexander Fröhlich, Christian Autermann, G. P. Van Onsem, Martti Raidal, Abraham Tishelman-Charny, J. Fernandez Menendez, Giorgio Maggi, S. Van Putte, John Roberts, Stefan Grünendahl, Deborah Pinna, Diogo Bastos, Danyyl Brzhechko, Kenneth Bloom, Thomas Perry, R. M. Brown, M. Naimuddin, Jose Flix, Tyler Ruggles, Smarajit Karmakar, Elizabeth Locci, Arnaud Steen, H. S. Chen, Robert Schöfbeck, Gabriel Madigan, A. B. Meyer, J. Park, Caleb Fangmeier, S. Cerci, Vinicius Massami Mikuni, D. R. Mendis, B. Álvarez González, Stephen Wimpenny, Henning Flacher, Davide Valsecchi, G. Quast, Igor Vorobiev, Hannsjoerg Artur Weber, Gordon H. Hanson, Martin Delcourt, Christophe Royon, Elizabeth Sexton-Kennedy, Bobae Kim, Matthias Wolf, Paolo Ronchese, Badder Marzocchi, D. A. Sanz Becerra, Elisabetta Gallo, Vincenzo Ciriolo, Guo-Ming Chen, Menglei Sun, Konrad Deiters, Arabella Martelli, Jingzhou Zhao, Branislav Ristic, Nikolaos Manthos, Martin Grunewald, Seth Moortgat, Sébastien Gadrat, J. D. Ruiz Alvarez, Mayda Velasco, Ketino Kaadze, G. B. Mohanty, Giacomo Bruno, Ian Mcalister, M. Melo De Almeida, Christian Contreras-Campana, E. W. Vaandering, Alexander Titterton, Alexander Dierlamm, V. Re, Shirin Chenarani, Hannes Jung, Mark Saunders, Michal Szleper, Ettore Focardi, Burak Bilki, Alexander Zhokin, Martijn Mulders, Nicolò Trevisani, Dirk Krücker, Gianluca Cerminara, P. Sphicas, A. Rose, Santeri Laurila, Roberto Chierici, Chia-Ming Kuo, S. Kaur, Emanuela Barberis, A. Bragagnolo, P. Major, Nadia Pastrone, Fatma Boran, Michael Dittmar, Suman Bala Beri, Helena Bialkowska, Mia Liu, Ulascan Sarica, Nur Zulaiha Jomhari, Maria Toms, Muhammad Waqas, John Michael Marraffino, E. De La Cruz-Burelo, Kenneth Call, Daniel Denegri, Magda Diamantopoulou, Elena Voevodina, Philip Harris, Ioannis Papakrivopoulos, Jeremie Alexandre Merlin, Robert Clare, Lucas Torterotot, Patrizia Azzi, Maksym Titov, Daniel Klein, Federico Ferri, Angelo Giacomo Zecchinelli, Douglas Berry, Igor Azhgirey, Frank Golf, A. M. Vargas Hernandez, German Martinez, T. Susa, Cristina Botta, Jonathon Langford, Marco Zanetti, U. Bhawandeep, Didier Contardo, Tae Jeong Kim, Emmanouil Vourliotis, John Hakala, Viesturs Veckalns, Michele Bianco, Antoine Lesauvage, Michael Murray, Jakob Salfeld-Nebgen, Louis Moureaux, Sebastian Wiedenbeck, Kunal Kothekar, Burin Asavapibhop, Xunwu Zuo, Siddhesh Sawant, D. Matos Figueiredo, Noemi Beni, K. S. Lee, M. Della Negra, Maria Isabel Josa, Pedro Silva, Song-Ming Wang, Sohini Sarkar, Kamal Lamichhane, Mary Hadley, Raffaele Gerosa, Alexander Ledovskoy, Vincent J Smith, F. Vazzoler, Shameena Bonomally, Thomas Hebbeker, Paul Lecoq, Joona Havukainen, Lorenzo Russo, Prasant Kumar Rout, Marc M Baarmand, Francesco Fallavollita, Panos A Razis, John Gabriel Acosta, Daniele Trocino, Paul Lujan, Regina Demina, Reyer Band, Boaz Klima, J. S. Kim, Michael Tytgat, David Lange, Robin Erbacher, Ian Laflotte, C. Mills, Hartmut Stadie, Natascha Krammer, Vivian O'Dell, Andrey Pozdnyakov, R. D. Field, Senta Greene, C. Baldenegro Barrera, Dylan Teague, Winston Ko, I. De Bruyn, Reza Goldouzian, Mohd Nizam Yusli, Vivan Nguyen, Junquan Tao, Vukasin Milosevic, Jozsef Molnar, Nikkie Deelen, Radia Redjimi, E. M. Da Costa, Prakash Thapa, Sourabh Dube, Gregor Kasieczka, I. Heredia-De La Cruz, O. Gonzalez Lopez, Alexander Schmidt, Izaak Neutelings, Nadir Daci, Olivér Surányi, Olena Karacheban, Predrag Milenovic, Roberto Dell'Orso, Tomas Kello, J. W. Gary, Sergey Troshin, Candan Dozen, Peter R Hobson, Kin Ho Lo, W. E. Johns, C. Diez Pardos, Michael Wayne Arenton, S. J. Qian, Rainer Mankel, Mariana Shopova, Eric Christian Chabert, Cesar Augusto Bernardes, J. S. H. Lee, Jean-Louis Faure, O. Kukral, Martino Margoni, Daniel Guerrero, Y. Chao, Riccardo Paramatti, Andrea Giammanco, Priyanka Kumari, Benjamin Krikler, Shalini Thakur, James John Brooke, Cédric Prieels, Laurent Thomas, Raffaella Tramontano, Mark Derdzinski, Sandeep Bhowmik, Miroslav Bonchev, Ernesto Migliore, Hans-Jürgen Simonis, Victor Murzin, Nicola Minafra, Johannes Schulz, Geonhee Oh, C. Martin Perez, M. Tadel, Eva Halkiadakis, Aleksandar Aleksandrov, Abhisek Datta, O. Hlushchenko, Tiziano Rovelli, Q. Li, F. Fiori, Martina Ressegotti, P. Schütze, J. Piedra Gomez, David D'Enterria, G. Bagliesi, C. Madrid, A. J. Campbell, Fengwangdong Zhang, A. David, Ksenia Shchelina, Albert M. Sirunyan, James Bueghly, Matthew Nguyen, Dario Bisello, Pascal Paganini, R. Walsh, Jonas Rembser, A. Scribano, K. Vellidis, E. Di Marco, Gaël Touquet, Yi-ting Duh, Boris Grynyov, Jeremi Niedziela, Y. Ershov, Lesya Shchutska, Andrea Massironi, Raffaella Radogna, Jacob Linacre, Yongbin Feng, Bernard Ille, Robert Hirosky, V. Rodríguez Bouza, Pedro G Mercadante, Hans-Christian Kaestli, Korbinian Schweiger, Frank Glege, Katja Klein, Wolfram Erdmann, Fabrice Couderc, Jens Multhaup, Nazar Bartosik, Ali Mohammadi, Dinko Ferencek, Marvin Johnson, Vladimir Ivanchenko, Sergey Guts, C. A. Carrillo Montoya, Anna Kropivnitskaya, Zoltan Gecse, P. de Barbaro, Giovanni Franzoni, Evrim Ersin Kangal, Ashok Kumar, Chiara Amendola, A. Di Florio, Rajat Gupta, Nadja Strobbe, Jean-Laurent Agram, G. Paspalaki, Anthony Moeller, Renato Potenza, Demetra Tsiakkouri, Shawn Zaleski, Todd Adams, Andrew Wightman, Vladimir Korotkikh, Wit Busza, Vyacheslav Valuev, Guenter Eckerlin, Denis Konstantinov, Shengquan Tuo, Tahereh Sadat Niknejad, R. F. Harr, Armen Tumasyan, J. De Clercq, Helio Nogima, Alberto Santoro, H. S. Kim, Luigi Benussi, A. Khan, Gouranga Kole, Bruno Galinhas, V. K. Muraleedharan Nair Bindhu, Nicolaus Kratochwil, Ravi Janjam, Siddharth Narayanan, Georg Auzinger, M. Aldaya Martin, Jindrich Lidrych, Elif Asli Yetkin, Alberto Orso Maria Iorio, Francesco Navarria, Sotiroulla Konstantinou, Oleksii Turkot, Grigory Safronov, Felice Pantaleo, Chanwook Hwang, Niladribihari Sahoo, Apichart Hortiangtham, Sudarshan Paramesvaran, Dezso Horvath, Victor Daniel Elvira, Yousen Zhang, Thoth Gunter, Kirti Ranjan, Michele Selvaggi, Milos Dordevic, Carsten Hensel, W. A. T. Wan Abdullah, Jamal Rorie, Jason Gilmore, Gulsen Onengut, Viktor Matveev, Bilal Kiani, Alexander Snigirev, Stephane Cooperstein, Manfred Paulini, Marco Paganoni, Jessica Prisciandaro, Pierluigi Bortignon, Don Lincoln, H. Lee, Li Yuan, Carlo Civinini, Clemens Lange, W. De Boer, Jory Sonneveld, Hafeez R Hoorani, K. Sandeep, F. Gasparini, Ren-Yuan Zhu, Ashish Sharma, Pascal Vanlaer, Richard Breedon, Olmo Cerri, Abhigyan Dasgupta, Alessandro Cardini, Ugo Gasparini, Veikko Karimäki, Zviad Tsamalaidze, Roger Rusack, M. M. Defranchis, Tielige Mengke, S. Ragazzi, G. B. Yu, Peter Robmann, Christina Reissel, Ryan Mueller, Robin Aggleton, Ferhat Ozok, Andreas Nürnberg, Prasanna Siddireddy, Garrett Funk, Anton Karneyeu, Leonard Apanasevich, M. Vander Donckt, T. Geralis, Mateusz Zarucki, Antoni Shtipliyski, Jochen Schieck, A. De Wit, Frans Meijers, Stephen Trembath-Reichert, Tiziano Camporesi, Olivier Davignon, G. L. Pinna Angioni, Francisco Yumiceva, Brent Stone, Ritva Kinnunen, Petar Maksimovic, F. De Guio, CristinaF. Bedoya, Louise Skinnari, Vito Palladino, Nural Akchurin, Zaixin Wang, Sara Fiorendi, Markus Radziej, Roberto Mulargia, Dylan Gilbert, Irene Dutta, M. L. Vesterbacka Olsson, Jim Hanlon, D. Soldi, Rishi Patel, Y. D. Oh, Daniel Gonzalez, P. A. Piroué, Hessamoddin Kaveh, Christopher George Tully, Paula Eerola, Manoj Sharan, Sebastian Wozniewski, Matthias Schröder, Edward Scott, Fabrizio Palla, A. Rossi, I. Dremin, P. De Castro Manzano, Kyungwook Nam, Anthony Lefeld, Souvik Das, Samila Muthumuni, Aristotelis Kyriakis, Gianni Masetti, Márton Bartók, Marguerite Tonjes, Torben Dreyer, Alessia Tricomi, Nikolay Tyurin, David Mark Raymond, Welathantri Gd Dharmaratna, C. E. Flores, M. Pelliccioni, Roumyana Hadjiiska, Antonio Cassese, Charalambos Nicolaou, Harvey B Newman, Igor Smirnov, Niki Saoulidou, Jeffrey Berryhill, J. D. Tapia Takaki, Melike Akbiyik, Vytautas Dudenas, Santiago Folgueras, George Alverson, X. Y. Gao, Kerstin Hoepfner, Roman Kogler, Satoshi Hasegawa, Benjamin Kreis, Oleksii Toldaiev, Sercan Sen, John Strologas, Charles Maguire, J. R. González Fernández, S. Sánchez Navas, Jose Chinellato, Richard Cavanaugh, Clément Grimault, A. Kayis Topaksu, H. A. Salazar Ibarguen, Mark Pesaresi, Claudia Ciocca, S. Shmatov, Daniel John Karmgard, Manfred Jeitler, Rachael Bucci, Vasken Hagopian, Natalia Emriskova, F. Torres Da Silva De Araujo, Owen Baron, Vivekanand Jha, Steve Schnetzer, Klaas Padeken, G. M. Dallavalle, Bhargav Madhusudan Joshi, Georgios Krintiras, Markus Seidel, Mara Senghi Soares, Serguei Ganjour, Silvia Taroni, Maria Giulia Ratti, Renato Campanini, Natalia Lychkovskaya, Matteo Presilla, Zeynep Demiragli, Marina Kolosova, Rosamaria Venditti, W. J. Metzger, Yalcin Guler, Stefan A. Maier, Alexander Belyaev, Cecilia Elena Gerber, D. Domínguez Damiani, P. Das, Diego Beghin, Giuseppe Codispoti, M. Guchait, Alessandro Caratelli, Natale Demaria, Hannu Siikonen, Clemens Wöhrmann, Anna Teresa Meneguzzo, Frank Jensen, Marco Bozzo, I. Babounikau, A. Ranieri, Livia Soffi, R. B. Garg, Christopher Seez, N. Turini, Pierluigi Paolucci, E. O. Olaiya, Ravindra Kumar Verma, Christophe Delaere, E. Belchior Batista Das Chagas, Martina Malberti, D. Pérez Adán, J. Kaspar, D. P. Stickland, Roger Wolf, Zuhal Seyma Demiroglu, Thomas Strebler, Jay Dittmann, Darien Wood, Piotr Zalewski, C. Kleinwort, Xinmei Niu, Jyothsna Rani Komaragiri, Pawan Kumar Netrakanti, Claudio Campagnari, Alex Kamenev, Victor Kim, Alberto Ruiz-Jimeno, Willem Verbeke, Armando Lanaro, Stephanie Brandt, Rui Xiao, Kevin Burkett, John Rander, A. Di Crescenzo, Martin Adams, Ivan Pozdnyakov, Ruchi Chudasama, Ferenc Sikler, Mauro Verzetti, Timo Peltola, Mario Kadastik, Marco Rovere, Alexander Dermenev, Michael Schmitt, Minseok Oh, Carlo Rovelli, Siarhei Shulha, Bobak Hashemi, Tom Cornelis, Shivali Malhotra, Tanmay Mudholkar, Ennio Monteil, Aldo Penzo, K. Wong, Silvio Donato, Lalit Mohan Pant, Paolo Gunnellini, Nicolas Tonon, Artur Gottmann, Daniel Bloch, Mohamed Rashad Darwish, Aaron Dominguez, Jason M. Hogan, Patrick Janot, S. Afanasiev, Andrés G Delannoy, Christopher Hill, Vivek Sharma, A. Álvarez Fernández, Narumon Suwonjandee, Kun Shi, Aimilios Ioannou, Juliet Ritchie Patterson, Giuseppe Benedetto Cerati, Felicitas Pauss, Yen-Jie Lee, Stavros Mallios, James D. Olsen, Ada Solano, Wolfgang Lohmann, Kevin Black, Aurélien Carle, Geoffrey Smith, Doga Gulhan, Louis Lyons, N. V. Krasnikov, Vineet Kumar, Yeonju Go, A. Vagnerini, Christophe Ochando, Jennifer Chu, J. H. Kim, B. De La Cruz, Jose F Benitez, Viktor Khristenko, Jeremy Andrea, Jaana Kristiina Heikkilä, Hugues Lattaud, Francesco Santanastasio, Samuel Higginbotham, Salvatore Costa, Gaël Perrin, Mauro Donegà, Igor Bayshev, Redwan Habibullah, H. Keller, Carlos Lourenco, Umesh Joshi, Marta Verweij, Stoyan Stoynev, A. Sanchez-Hernandez, Jan Tomsa, V. Papadimitriou, Thorsten Chwalek, Tongguang Cheng, Najaf Amin, A. Braghieri, Harry Cheung, Evgueni Tcherniaev, K. A. Ulmer, Vitalii Okhotnikov, Petar Adzic, Sergo Jindariani, Bruno Lenzi, J. Schwandt, Berkan Kaynak, Marc Osherson, J. Puerta Pelayo, Indara Suarez, Yong Ban, Devdatta Majumder, A. Vorobyev, Filip Moortgat, Ruslan Chistov, Kadri Ozdemir, Angira Rastogi, Joao Varela, Aobo Zhang, M. G. Albrow, Konstantinos Kousouris, Arne Reimers, Joshua Bendavid, Anne Dabrowski, Bryan Caraway, T. Y. Ling, J. S. Lange, Leander Litov, Jean-Pierre Merlo, Dong Ho Moon, Austin Baty, Walaa Elmetenawee, Adam Elwood, Sami Lehti, Julie Malcles, Matteo Cremonesi, Paolo Giacomelli, Nitish Dhingra, Ian Watson, Isabell-Alissandra Melzer-Pellmann, Nicholas John Hadley, Jehad Mousa, J. Suarez Gonzalez, You-ying Li, Samuel Bein, Daniel Spitzbart, Irina Vardanyan, Doris Eckstein, Achim Geiser, Batoul Diab, Joanne Cole, A. K. Virdi, Alexander Morton, Javier Cuevas, Marco Toliman Lucchini, Mauricio Thiel, Eija Tuominen, Tariq Aziz, Nicanor Colino, Dave M Newbold, Luca Perrozzi, Manfred Krammer, Caleb Smith, Florian Michael Pitters, Mikhail Kirsanov, R. Cousins, B. Fabbro, Giovanni Abbiendi, Ilya Gorbunov, Marcello Abbrescia, Sanjay Kumar, Maciej Górski, Andrea Malara, P. Rebello Teles, Amandeep Kaur Kalsi, Leonard Spiegel, Stephanie Kwan, Peter Timothy Cox, Kevin Sung, Alexander Bylinkin, Torben Lange, Michael Mulhearn, J. G. Li, Roberto Rossin, Thomas Bergauer, Rostyslav Shevchenko, Patrick Asenov, Konstanty Sumorok, Karl Matthew Ecklund, Dragos Velicanu, Qamar Hassan, A. Rizzi, Maral Alyari, Nuno Leonardo, Heriberto Castilla-Valdez, Ashutosh Bhardwaj, D. Kim, Francesco Romeo, Daniel Savoiu, Adish Vartak, Maria Margherita Obertino, Engin Eren, P. Van Mulders, Michele Gallinaro, Alexey Golunov, P. H. Butler, Tommaso Isidori, Mirza Awais Ahmad, Giorgia Miniello, Peter Wittich, Valentin Sulimov, Francesco Fabozzi, Michal Olszewski, Shin-Shan Yu, Wenxing Fang, Kirika Uchida, William Mcbrayer, G. N. Kim, Valentina Mariani, Stefaan Tavernier, Daniel Teyssier, Patrick Connor, Ivan Shvetsov, Diego Ciangottini, Giovanna Selvaggi, Georgios Tsipolitis, P. Van Mechelen, A. Apyan, Andrew Beretvas, Otto Hindrichs, Sanjay Padhi, Giuliana Galati, Danila Tlisov, Geng-Yuan Jeng, Daniel Abercrombie, Andrey Popov, Samuel Nathan Webb, Giovanni Mocellin, Gabor Istvan Veres, Marko Dragicevic, Adel Terkulov, Caglar Zorbilmez, Kelly Beernaert, Peter Raics, Peicho Petkov, Leonardo Cristella, Erik Brücken, Achille Petrilli, Chun-Hua Jiang, G. Ortona, Robert Klanner, Andrea Benaglia, Peter Schleper, Zhen Hu, W. Haj Ahmad, Zoltan Laszlo Trocsanyi, J. Conway, D. Del Re, Vincent Lemaitre, K. Wichmann, P. Kyberd, Davide Fiorina, Paul Baillon, Artur Apresyan, Marc Besancon, Dinyar Rabady, Wolfram Dietrich Zeuner, Malgorzata Kazana, Mikhail Danilov, Pieter David, Olga Evdokimov, Junghwan Goh, George Karathanasis, Y. Choi, Livio Fanò, M. Weber, Aruna Nayak, J. H. Yoo, Darin Acosta, Jongjeong Kim, Kristian Allan Hahn, Daniele Bonacorsi, Nicholas Haubrich, Erich Schmitz, Lutz Feld, Shahram Rahatlou, A. Richards, Igor Golutvin, Mircho Rodozov, Jennifer Ngadiuba, Á. Navarro Tobar, Attila Racz, Roberta Arcidiacono, Christian Schnaible, Jonathan Fulcher, Anatoli Pashenkov, Avto Kharchilava, Mikhail Ignatenko, Tapio Lampén, Carlos Willmott, R. Del Burgo, Vladimir Mossolov, Aleksandr Iuzhakov, M. Bharti, V. Sola, P. C. Tiwari, Emrah Tiras, A. M. Rossi, Toyoko Orimoto, Th. Müller, Paul Sheldon, Yuichi Kubota, Andreas Albert, Sushil Chauhan, Kajari Mazumdar, Bolek Wyslouch, Nickolas Mccoll, Victor Perelygin, Manisha Lohan, Alessandra Fanfani, J. Duarte Campderros, Frixos A Triantis, Andrew Askew, R. L. Lander, Nicholas Menendez, M. Olmedo Negrete, Miao Hu, Duje Giljanovic, Brandon Allen, Dustin Burns, Prabhat Ranjan Pujahari, Norraphat Srimanobhas, Dermot Moran, Sabino Meola, Roberto Covarelli, Claudio Caputo, Santosh K. Swain, J. Lykken, Pasquale Musella, Yangyang Cheng, Andrea Bocci, Sarah Catherine Eno, Jan-Frederik Schulte, Sihyun Jeon, Pirmin Berger, Tommaso Dorigo, Vladislav Borchsh, Sandra Malvezzi, Pieter Everaerts, Titas Roy, Alexx Perloff, Roman Ryutin, Federica Primavera, Roberto Carlin, B. Chazin Quero, Dener De Souza Lemos, Panagiotis Kokkas, S. K. Pflitsch, Niels Dupont, Zhengcheng Tao, Sergio Cittolin, Jared Sturdy, Kaya Tatar, A. Bornheim, J. M. Hernandez, Edward Laird, Aurore Savoy-Navarro, L. J. Gutay, V. Andreev, Grace Cummings, Francesco Fienga, Roy Montalvo, R. Sharma, Rishika Bhardwaj, Simon Christoph Schuler, János Karancsi, Alexander Ershov, Vladimir Cherepanov, Hasan Ogul, Don Upul Jayasiri Sonnadara, John Perry Cumalat, Swagata Mukherjee, Toni Sculac, Todor Ivanov, T. Bose, Inkyu Park, Xuejun Wang, M. Ramirez-Garcia, Sandra S. Padula, Yiwen Wen, Paolo Vitulo, Irene Bachiller, William J Spalding, Micael Verissimo de Araujo, Stefano Bianco, Brandon Chiarito, Luca Mastrolorenzo, W. L. Prado Da Silva, Vieri Candelise, S. Mitra, Aashaq Shah, T. Tabarelli de Fatis, Andrew Hart, Demetrios Loukas, Erik Butz, Pietro Faccioli, Jan Kieseler, D. H. Kim, Giulia Negro, Pierre Depasse, M. Van De Klundert, Oliver Gutsche, Ted Kolberg, C. Uribe Estrada, Muhammad Shoaib, Didar Dobur, Himal Acharya, S. Goy Lopez, Q. Wang, Maria Spiropulu, L. J. Sanchez Rosas, Christian Dorfer, Victor Golovtcov, Alberto Zucchetta, V. Petrov, Gervasio Gomez, A. Delgado Peris, Matthew Herndon, Elisa Fontanesi, Vasilije Perovic, Marcus Hohlmann, Richard B. Lipton, Thomas James, Elsayed Salama, Sevgi Tekten, Karl Gill, Sharad Malik, Shengxue Zhang, Yury Ivanov, Claude Charlot, Andre Sznajder, Serdal Damarseckin, A. P. Singh, Yuri Gershtein, Ali Celik, R. Bi, Reddy Pratap Gandrajula, Yacine Haddad, Markus Stoye, Rohan Bhandari, Vinay Hegde, Shao Min Tan, Ashraf Mohamed, A. Reinsvold Hall, Urs Langenegger, Ivan Mikulec, Gul Gokbulut, Savvas Kyriacou, Denis Rathjens, Kai Yi, C. Wissing, A. Castaneda Hernandez, Ivan Reid, Christine Mclean, Anastasia Grebenyuk, G. Dissertori, Carlos Florez, Ilaria Vai, Abhishikth Mallampalli, Nicolas Postiau, Marco Musich, Konstantin Androsov, Jovan Milosevic, Vitaliano Ciulli, Emmanuelle Perez, G. G. Da Silveira, Cristina Riccardi, Apostolos Panagiotou, Benjamin Kilminster, Benjamin Fischer, S. Sanchez Cruz, Antonin Kveton, Mauro Menichelli, A. Da Rold, Luca Perniè, Roland Horisberger, Ilya Kravchenko, Jeroen Hegeman, Joachim Baechler, Maria Teresa Grippo, Alexandre Zabi, Georgios Mavromanolakis, Michele Arneodo, Garvita Agarwal, Christopher Mcginn, Daniel Robert Marlow, S. M. A. Ghiasi Shirazi, Anatoli Zarubin, Federica Maria Simone, Andreas Pfeiffer, Alessandra Cappati, Kreso Kadija, Marino Missiroli, Dmitry Hits, Gilvan Alves, Jorma Tuominiemi, David Stuart, Alice Mignerey, A. Benecke, Evgenii Tarkovskii, Stefanos Leontsinis, Chayanit Asawatangtrakuldee, Y. C. Yang, Guillaume Falmagne, Aniello Spiezia, Christopher West, Jonas Roemer, Zhoudunming Tu, Isabel Ojalvo, S. H. Lee, Elisa Manoni, Ka Tung Lau, S. Luo, Brieuc Francois, Youn Roh, Barry Blumenfeld, T. V. Dimova, Adrian Byszuk, Yuri Skovpen, A. Starodumov, Paul Edmund Karchin, Thomas Madlener, G. F. Chen, Christopher Rogan, Andrius Juodagalvis, Ricardo Lopez-Fernandez, Austin Ball, David Zou, Finn Feindt, Pritam Kalbhor, A. Di Mattia, Andrey Korytov, P. Chang, Crisostomo Sciacca, Imad Baptiste Laktineh, Maxim Goncharov, Eduardo De Moraes Gregores, Haiyan Wang, Lucas Taylor, Matthew Citron, G. De Lentdecker, Marco Cuffiani, S. Baur, Yves Sirois, Li Li, O. Zenaiev, Oliver Buchmuller, S. M. Spanier, Candan Isik, Zukhaimira Zolkapli, Vladimir Blinov, Nathaniel Odell, Dan J. Krofcheck, James Wetzel, Ivan Vila, S. Carrillo Moreno, Leszek Grzanka, Andrea Gozzelino, A. Pérez-Calero Yzquierdo, Nicolas Chanon, Helena Malbouisson, Alex J. Barker, Sarah Freed, Alexander Toropin, Alicia Calderon, Seyed Mohsen Etesami, Hyunyong Kim, Kirill Skovpen, S. Lo Meo, Ashfaq Ahmad, Camelia Mironov, Valentina Avati, Anton Petrov, Vladimir Korenkov, Kerstin Borras, Rudy Ceccarelli, S. Seif El Nasr-storey, Baokai Wang, Dong-Chul Son, Sandra Oliveros, Benedikt Vormwald, Ilknur Hos, K. Ehataht, Marco Pieri, Alfredo Gurrola, Ufuk Guney Tok, Christopher Brew, A. Moraes, Tomas Lindén, J. N. Butler, Genius Walia, Paolo Lariccia, Dmitry Sosnov, Christoph Garbers, Muhammad Ansar Iqbal, N. Van Remortel, Alice Florent, Ian R Tomalin, David Saltzberg, Svenja Schumann, Liliana Teodorescu, Daniel Pitzl, Rami Kamalieddin, P. Busson, Gintautas Tamulaitis, Lothar At Bauerdick, Leonardo Giannini, Aaron Bundock, Katerina Lipka, Martin Kirakosyan, Chad Freer, Stefan Piperov, Fabio Iemmi, G. P. Siroli, Georgios Bakas, Y. Wang, F. Vazquez Valencia, Clément Leloup, Alexander Nikitenko, Jasvinder A. Singh, Matthias Schnepf, M. P. Rauch, M. Rahmani, Vladimir Epshteyn, Dipanwita Dutta, Meena Meena, Daniel Marley, Georgy Antchev, Daniel Rosenzweig, Bhumika Kansal, Ashim Roy, Alexei Safonov, Andre Frankenthal, Andres Tiko, Andrea Triossi, Christoph Schwick, M. Aguilar-Benitez, Janos Erö, Michael Revering, Vladimir Palichik, Julia Velkovska, Sudha Ahuja, Nikolai Gorbounov, Halil Saka, Pietro Govoni, Sa. Jain, J. Vaitkus, V. Myronenko, Simone Gennai, Bibhuprasad Mahakud, G. Gomez Ceballos, Nikos Varelas, Helen F Heath, Joshua Hiltbrand, J. Choi, Joaquin Emilo Siado, Maksat Haytmyradov, Paolo Montagna, EmineGurpinar Guler, Caroline Elisabeth Niniane Niemeyer, Jan Krolikowski, Luiz Mundim, Duccio Abbaneo, Matteo Bonanomi, Kenichi Hatakeyama, Luc Pape, William Arthur Nash, Anna Woodard, Petr Levchenko, Marco Costa, Vassili Kachanov, Moritz Guthoff, Nikolai Golubev, S. Fonseca De Souza, Giuseppe Barbagli, Ioanna Papavergou, David Sperka, Gaelle Boudoul, Alexis Kalogeropoulos, Leonid Chtchipounov, D. Sunar Cerci, Isa Dumanoglu, Cristina Biino, Limin Wang, Gabriele Benelli, Simone Pigazzini, Reham Aly, S. Slabospitskii, James Keaveney, D. R. Claes, Marcel Rieger, Anders Ryd, Gavin Davies, Metin Yalvac, Stephan Lammel, J. Madhusudanan Sreekala, Othmane Bouhali, Milan Stojanovic, Carlos Erice, H. Zhang, David Mason, Luigi Moroni, Hugo Delannoy, Daniel Noonan, M. H.L.S. Wang, Olaf Behnke, Constantin Heidegger, Natasa Raicevic, Patrizia Barria, Sourav Chatterjee, Elio Usai, Somnath Choudhury, M. Alhusseini, John Alison, Aliakbar Ebrahimi, Gianni Zumerle, Sunil Bansal, Wing Yan Wong, Maciej Malawski, Xin Chen, Teresa Rodrigo, Alexander Lanev, Markus Spanring, T. Kress, Susan Dittmer, N. De Filippis, Georgios Daskalakis, Alessandra Romero, Sergei Gninenko, J. C. Freeman, Petr Mandrik, M. Shi, Senka Duric, Benjamin Tannenwald, Evgueni Vlasov, Nicholas Smith, Luca Lista, Jean-Charles Fontaine, Anton Dimitrov, Luciano Di Fiore, L. R. Sulak, M. A. Segura Delgado, Kurtis F Johnson, Greg P Heath, Werner Lustermann, Andromachi Tsirou, Guler Karapinar, S. Petrushanko, R. Granier de Cassagnac, Maxime Gouzevitch, Andrea Beschi, H. Van Haevermaet, Sam Harper, Shuichi Kunori, Marek Niedziela, James Strait, Christoph Schäfer, Samuel May, Giuseppe Latino, Matthew Kilpatrick, Alessandro Giassi, Alexander Grohsjean, Dimitrios Tsitsonis, Samandeep Sharma, Lev Uvarov, He He, Rajdeep Mohan Chatterjee, Süleyman Durgut, John Paul Chou, Rishabh Uniyal, Brian Paul Padley, Justin Williams, Yi Chen, Zhaozhong Shi, Nairit Sur, Radek Zlebcik, Gregory Iles, Debabrata Bhowmik, A. Meyer, Russell Richard Betts, Conor Henderson, A. Hervé, Prasenjit Mal, Christina Snyder, Konstantin Matchev, Jean-Marie Brom, Xavier Coubez, Teresa Lenz, Laurent Mirabito, Steven Lowette, Egidio Longo, Francesca Ricci-Tam, Ivan Marchesini, Mohsan Waseem Ather, Anna Stakia, Jonathan Hollar, Sébastien Wertz, J. P. Fernández Ramos, S. Gianì, Andrew Evans, Salvatore Rappoccio, L. Kreczko, Loukas Gouskos, C. F. González Hernández, Maksim Azarkin, J. Alcaraz Maestre, Basil Schneider, Xavier Janssen, Nicolo Cartiglia, Shane Breeze, Iban Jose Cabrillo, Roberto Leonardi, Alexander Barnyakov, Markus Merschmeyer, Arie Bodek, Eduardo Coelho, Ozlem Kaya, Sevil Salur, Hong Ni, W. T. Ford, P. J. Fernández Manteca, Luca Guzzi, Pierluigi Zotto, Hwi Dong Yoo, Robert Bainbridge, K. Hurtado Anampa, Jian Wang, Virgil E Barnes, Andrzej Novak, Graham Wilson, Alessio Ghezzi, Abideh Jafari, T. Berger, Johannes Haller, Vadim Oreshkin, Francesca Cavallari, M. J. Kim, Paolo Dini, S. Bheesette, Fabio Ravera, Maren Tabea Meinhard, Rogelio Reyes-Almanza, Nikola Godinovic, Hualin Mei, Altan Cakir, Paolo Meridiani, Aron Soha, Simon Kurz, A. Bat, Elizabeth Starling, Nan Lu, René Caspart, Elisabetta Manca, Christoph Grab, Henning Kirschenmann, Edouard Boos, Stephane Perries, Costas Foudas, Anna Zacharopoulou, C. A. Salazar González, Dominique Gigi, Raffaello D'Alessandro, Slawek Tkaczyk, Raghunath Pradhan, Andrei Sobol, H. Bakhshiansohi, Gabriella Pasztor, A. De Roeck, T. R. Fernandez Perez Tomei, Hao Qiu, Muhammad Imran Malik Awan, Claudia Pistone, Wolfgang Adam, G. Zevi Della Porta, Marc Dünser, Federico Ambrogi, Marcos Cerrada, Andrei Gritsan, William Tabb, C. Neu, Thong Nguyen, David Overton, Sang Il Pak, Gabriel B. Hall, Tejinder Virdee, Nicolò Tosi, M. Jones, Camilla Galloni, Seth Conrad Zenz, Vincenzo Daponte, Finn Rebassoo, Joshua Hardenbrook, Neeti Parashar, W. T. Hung, Klaus Rabbertz, Sebastiano Albergo, Igor Lokhtin, Myriam Schönenberger, Zachary Lesko, Gabriella Pugliese, Biagio Rossi, Sanchita Bhattacharya, Kevin Lannon, G. Della Ricca, Guenakh Mitselmakher, S. Orfanelli, Jordan Damgov, D. Di Croce, Kisung Lee, Francisco Garcia, Basile Vermassen, Jay Mathew Lawhorn, Claude Amsler, Brent Yates, S. Roy Chowdhury, Andrea Bellora, Laurent Favart, Cristian Pena, Thomas Reis, Martin Lipinski, Frank Würthwein, Manas Maity, Alexi Mestvirishvili, Ulrich Goerlach, Joze Zobec, Massimo Casarsa, Steve Nahn, Marco Meschini, Paolo Capiluppi, Frigyes Nemes, James Rohlf, Carlos Avila, Sergei Bitioukov, Ricardo Eusebi, J. Seixas, Merve Ince, Suyong Choi, Etiennette Auffray, Maurizio Biasini, D. R. Muller, A. Yagil, Sinan Sagir, Marta Felcini, Nikitas Loukas, Mani Tripathi, Rachel Bartek, Marco Peruzzi, Usama Hussain, Owen Rosser Long, Dana Z. Anderson, Cesare Calabria, M. Csanad, Nicola Amapane, Andreas Nowack, Koushik Mandal, Michael Reichmann, Anton Babaev, Dennis Noll, Maria Agnese Ciocci, Maria Florencia Canelli, Fabrizio Ferro, Thomas Ferbel, J. Thom, Marta Ruspa, Stepan Obraztsov, Anshul Kapoor, M. A. Bhat, C. S. Moon, J. Mejia Guisao, Damarseçkin, Serdal, Institut de Recherches sur les lois Fondamentales de l'Univers (IRFU), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, Laboratoire Leprince-Ringuet (LLR), Centre National de la Recherche Scientifique (CNRS)-École polytechnique (X)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3), Institut Pluridisciplinaire Hubert Curien (IPHC), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS), Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA)), Centre de Calcul de l'IN2P3 (CC-IN2P3), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), Institut de Physique Nucléaire de Lyon (IPNL), Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3), CMS, Yerevan Phys Inst, Inst Hochenergiephys, Inst Nucl Problems, Univ Antwerp, Vrije Univ Brussel, Univ Libre Bruxelles, Univ Ghent, Catholic Univ Louvain, Ctr Brasileiro Pesquisas Fis, Universidade do Estado do Rio de Janeiro (UERJ), Universidade Estadual Paulista (Unesp), Universidade Federal do ABC (UFABC), Bulgarian Acad Sci, Univ Sofia, Beihang Univ, Tsinghua Univ, Inst High Energy Phys, Peking Univ, Zhejiang Univ, Univ Los Andes, Univ Antioquia, Univ Split, Inst Rudjer Boskovic, Univ Cyprus, Charles Univ Prague, Escuela Politec Nacl, Univ San Francisco Quito, Egyptian Network High Energy Phys, NICPB, Univ Helsinki, Helsinki Inst Phys, Lappeenranta Univ Technol, Univ Paris Saclay, Ecole Polytech, Univ Strasbourg, Univ Claude Bernard Lyon 1, Georgian Tech Univ, Tbilisi State Univ, Rhein Westfal TH Aachen, DESY, Univ Hamburg, Karlsruher Inst Technol, NCSR Demokritos, Natl & Kapodistrian Univ Athens, Natl Tech Univ Athens, Univ Ionnina, Eotvos Lorand Univ, Wigner Res Ctr Phys, Inst Nucl Res ATOMKI, Univ Debrecen, Eszterhazy Karoly Univ, Indian Inst Sci IISc, HBNI, Panjab Univ, Univ Delhi, Indian Inst Technol Madras, Bhabha Atom Res Ctr, Tata Inst Fundamental Res A, Tata Inst Fundamental Res B, Indian Inst Sci Educ & Res IISER, Inst Res Fundamental Sci IPM, Univ Coll Dublin, Ist Nazl Fis Nucl, Univ Bari, Politecn Bari, Univ Bologna, Univ Catania, Univ Firenze, Univ Genoa, Univ Milano Bicocca, Univ Napoli Federico II, Univ Basilicata, Univ G Marconi, Univ Padua, Univ Pavia, Univ Perugia, Univ Pisa, Scuola Normale Super Pisa, Sapienza Univ Roma, Univ Torino, Univ Piemonte Orientale, Univ Trieste, Kyungpook Natl Univ, Chonnam Natl Univ, Hanyang Univ, Korea Univ, Kyung Hee Univ, Sejong Univ, Seoul Natl Univ, Univ Seoul, Sungkyunkwan Univ, Riga Tech Univ, Vilnius Univ, Univ Malaya, Univ Sonora UNISON, IPN, Univ Iberoamer, Benemerita Univ Autonoma Puebla, Univ Autonoma San Luis Potosi, Univ Montenegro, Univ Auckland, Univ Canterbury, Quaid I Azam Univ, AGH Univ Sci & Technol, Natl Ctr Nucl Res, Univ Warsaw, Lab Instrumentacao & Fis Expt Particulas, Joint Inst Nucl Res, Petersburg Nucl Phys Inst, Inst Nucl Res, NRC Kurchatov Inst, Moscow Inst Phys & Technol, Natl Res Nucl Univ, PN Lebedev Phys Inst, Lomonosov Moscow State Univ, Novosibirsk State Univ NSU, Natl Res Ctr, Natl Res Tomsk Polytech Univ, Tomsk State Univ, Univ Belgrade, Ctr Invest Energet Medioambientales & Tecnol CIEM, Univ Autonoma Madrid, Univ Oviedo, Univ Cantabria, Univ Colombo, Univ Ruhuna, European Org Nucl Res, Paul Scherrer Inst, Swiss Fed Inst Technol, Univ Zurich, Natl Cent Univ, Natl Taiwan Univ NTU, Chulalongkorn Univ, Cukurova Univ, Middle East Tech Univ, Bogazici Univ, Istanbul Tech Univ, Istanbul Univ, Natl Acad Sci Ukraine, Kharkov Inst Phys & Technol, Univ Bristol, Rutherford Appleton Lab, Imperial Coll, Brunel Univ, Baylor Univ, Catholic Univ Amer, Univ Alabama, Boston Univ, Brown Univ, Univ Calif Davis, Univ Calif Los Angeles, Univ Calif Riverside, Univ Calif San Diego, Univ Calif Santa Barbara, CALTECH, Carnegie Mellon Univ, Univ Colorado, Cornell Univ, Fermilab Natl Accelerator Lab, Univ Florida, Florida Int Univ, Florida State Univ, Florida Inst Technol, Univ Illinois Chicago UIC, Univ Iowa, Johns Hopkins Univ, Univ Kansas, Kansas State Univ, Lawrence Livermore Natl Lab, Univ Maryland, MIT, Univ Minnesota, Univ Mississippi, Univ Nebraska, SUNY Buffalo, Northeastern Univ, Northwestern Univ, Univ Notre Dame, Ohio State Univ, Princeton Univ, Univ Puerto Rico, Purdue Univ, Purdue Univ Northwest, Rice Univ, Univ Rochester, Rutgers State Univ, Univ Tennessee, Texas A&M Univ, Texas Tech Univ, Vanderbilt Univ, Univ Virginia, Wayne State Univ, Univ Wisconsin, Vienna Univ Technol, Universidade Estadual de Campinas (UNICAMP), Univ Fed Rio Grande do Sul, Universidade Federal de Mato Grosso do Sul (UFMS), Univ Fed Pelotas, Univ Chinese Acad Sci, Zewail City Sci & Technol, British Univ Egypt, Ain Shams Univ, Univ Haute Alsace, Erzincan Binali Yildirim Univ, Brandenburg Tech Univ Cottbus, IIT Bhubaneswar, Inst Phys, GHG Khalsa Coll, Shoolini Univ, Univ Hyderabad, Univ Visva Bharati, Italian Natl Agcy New Technol Energy & Sustainabl, Ctr Siciliano Fis Nucl & Struttura Mat, MOSTI, Consejo Nacl Ciencia & Technol, Warsaw Univ Technol, St Petersburg State Polytech Univ, Univ Trento, Budker Inst Nucl Phys, Univ Siena, Stefan Meyer Inst Subatom Phys, Burdur Mehmet Akif Ersoy Univ, Sirnak Univ, Near East Univ, Beykent Univ, Istanbul Aydin Univ, Mersin Univ, Piri Reis Univ, Ozyegin Univ, Izmir Inst Technol, Bozok Univ Rektorlugu, Marmara Univ, Milli Savunma Univ, Kafkas Univ, Istanbul Bilgi Univ, Hacettepe Univ, Adiyaman Univ, Univ Southampton, Univ Durham, Monash Univ, Bethel Univ, Karamanoglu Mehmetbey Univ, Bingol Univ, Sinop Univ, Mimar Sinan Univ, Nanjing Normal Univ, Texas A&M Univ Qatar, Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-École polytechnique (X)-Centre National de la Recherche Scientifique (CNRS), Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), ANR-16-CE31-0002,HotShowers,Modification des gerbes partoniques dans le plasma de quarks et de gluons(2016), Universidad de Cantabria, UAM. Departamento de Física Teórica, Department of Physics, Helsinki Institute of Physics, CMS Collaboration, Sağır, Sinan, Principado de Asturias, European Research Council, European Commission, Centre National de la Recherche Scientifique (France), Ministerio de Economía y Competitividad (España), Sirunyan A.M., Tumasyan A., Adam W., Ambrogi F., Bergauer T., Dragicevic M., Ero J., Escalante Del Valle A., Flechl M., Fruhwirth R., Jeitler M., Krammer N., Kratschmer I., Liko D., Madlener T., Mikulec I., Rad N., Schieck J., Schofbeck R., Spanring M., Waltenberger W., Wulz C.-E., Zarucki M., Drugakov V., Mossolov V., Suarez Gonzalez J., Darwish M.R., De Wolf E.A., Di Croce D., Janssen X., Kello T., Lelek A., Pieters M., Rejeb Sfar H., Van Haevermaet H., Van Mechelen P., Van Putte S., Van Remortel N., Blekman F., Bols E.S., Chhibra S.S., D'Hondt J., De Clercq J., Lontkovskyi D., Lowette S., Marchesini I., Moortgat S., Python Q., Tavernier S., Van Doninck W., Van Mulders P., Beghin D., Bilin B., Clerbaux B., De Lentdecker G., Delannoy H., Dorney B., Favart L., Grebenyuk A., Kalsi A.K., Moureaux L., Popov A., Postiau N., Starling E., Thomas L., Vander Velde C., Vanlaer P., Vannerom D., Cornelis T., Dobur D., Khvastunov I., Niedziela M., Roskas C., Skovpen K., Tytgat M., Verbeke W., Vermassen B., Vit M., Bruno G., Caputo C., David P., Delaere C., Delcourt M., Giammanco A., Lemaitre V., Prisciandaro J., Saggio A., Vischia P., Zobec J., Alves G.A., Correia Silva G., Hensel C., Moraes A., Belchior Batista Das Chagas E., Carvalho W., Chinellato J., Coelho E., Da Costa E.M., Da Silveira G.G., De Jesus Damiao D., De Oliveira Martins C., Fonseca De Souza S., Malbouisson H., Martins J., Matos Figueiredo D., Medina Jaime M., Melo De Almeida M., Mora Herrera C., Mundim L., Nogima H., Prado Da Silva W.L., Rebello Teles P., Sanchez Rosas L.J., Santoro A., Sznajder A., Thiel M., Tonelli Manganote E.J., Torres Da Silva De Araujo F., Vilela Pereira A., Bernardes C.A., Calligaris L., Fernandez Perez Tomei T.R., Gregores E.M., Lemos D.S., Mercadante P.G., Novaes S.F., Padula S.S., Aleksandrov A., Antchev G., Hadjiiska R., Iaydjiev P., Misheva M., Rodozov M., Shopova M., Sultanov G., Bonchev M., Dimitrov A., Ivanov T., Litov L., Pavlov B., Petkov P., Petrov A., Fang W., Gao X., Yuan L., Ahmad M., Hu Z., Wang Y., Chen G.M., Chen H.S., Chen M., Jiang C.H., Leggat D., Liao H., Liu Z., Spiezia A., Tao J., Yazgan E., Zhang H., Zhang S., Zhao J., Agapitos A., Ban Y., Chen G., Levin A., Li J., Li L., Li Q., Mao Y., Qian S.J., Wang D., Wang Q., Xiao M., Avila C., Cabrera A., Florez C., Gonzalez Hernandez C.F., Segura Delgado M.A., Mejia Guisao J., Ruiz Alvarez J.D., Salazar Gonzalez C.A., Vanegas Arbelaez N., Giljanovic D., Godinovic N., Lelas D., Puljak I., Sculac T., Antunovic Z., Kovac M., Brigljevic V., Ferencek D., Kadija K., Majumder D., Mesic B., Roguljic M., Starodumov A., Susa T., Ather M.W., Attikis A., Erodotou E., Ioannou A., Kolosova M., Konstantinou S., Mavromanolakis G., Mousa J., Nicolaou C., Ptochos F., Razis P.A., Rykaczewski H., Saka H., Tsiakkouri D., Finger M., Kveton A., Tomsa J., Ayala E., Carrera Jarrin E., Mohamed A., Salama E., Bhowmik S., Carvalho Antunes De Oliveira A., Dewanjee R.K., Ehataht K., Kadastik M., Raidal M., Veelken C., Eerola P., Forthomme L., Kirschenmann H., Osterberg K., Voutilainen M., Brucken E., Garcia F., Havukainen J., Heikkila J.K., Karimaki V., Kim M.S., Kinnunen R., Lampen T., Lassila-Perini K., Laurila S., Lehti S., Linden T., Siikonen H., Tuominen E., Tuominiemi J., Luukka P., Tuuva T., Besancon M., Couderc F., Dejardin M., Denegri D., Fabbro B., Faure J.L., Ferri F., Ganjour S., Givernaud A., Gras P., Hamel de Monchenault G., Jarry P., Leloup C., Lenzi B., Locci E., Malcles J., Rander J., Rosowsky A., Sahin M.O., Savoy-Navarro A., Titov M., Yu G.B., Ahuja S., Amendola C., Beaudette F., Bonanomi M., Busson P., Charlot C., Diab B., Falmagne G., Granier de Cassagnac R., Kucher I., Lobanov A., Martin Perez C., Nguyen M., Ochando C., Paganini P., Rembser J., Salerno R., Sauvan J.B., Sirois Y., Zabi A., Zghiche A., Agram J.-L., Andrea J., Bloch D., Bourgatte G., Brom J.-M., Chabert E.C., Collard C., Conte E., Fontaine J.-C., Gele D., Goerlach U., Grimault C., Le Bihan A.-C., Tonon N., Van Hove P., Gadrat S., Beauceron S., Bernet C., Boudoul G., Camen C., Carle A., Chanon N., Chierici R., Contardo D., Depasse P., El Mamouni H., Fay J., Gascon S., Gouzevitch M., Ille B., Jain S., Laktineh I.B., Lattaud H., Lesauvage A., Lethuillier M., Mirabito L., Perries S., Sordini V., Torterotot L., Touquet G., Vander Donckt M., Viret S., Toriashvili T., Tsamalaidze Z., Autermann C., Feld L., Klein K., Lipinski M., Meuser D., Pauls A., Preuten M., Rauch M.P., Schulz J., Teroerde M., Erdmann M., Fischer B., Ghosh S., Hebbeker T., Hoepfner K., Keller H., Mastrolorenzo L., Merschmeyer M., Meyer A., Millet P., Mocellin G., Mondal S., Mukherjee S., Noll D., Novak A., Pook T., Pozdnyakov A., Quast T., Radziej M., Rath Y., Reithler H., Roemer J., Schmidt A., Schuler S.C., Sharma A., Wiedenbeck S., Zaleski S., Flugge G., Haj Ahmad W., Hlushchenko O., Kress T., Muller T., Nowack A., Pistone C., Pooth O., Roy D., Sert H., Stahl A., Aldaya Martin M., Asmuss P., Babounikau I., Bakhshiansohi H., Beernaert K., Behnke O., Bermudez Martinez A., Bin Anuar A.A., Borras K., Botta V., Campbell A., Cardini A., Connor P., Consuegra Rodriguez S., Contreras-Campana C., Danilov V., De Wit A., Defranchis M.M., Diez Pardos C., Dominguez Damiani D., Eckerlin G., Eckstein D., Eichhorn T., Elwood A., Eren E., Estevez Banos L.I., Gallo E., Geiser A., Grohsjean A., Guthoff M., Haranko M., Harb A., Jafari A., Jomhari N.Z., Jung H., Kasem A., Kasemann M., Kaveh H., Keaveney J., Kleinwort C., Knolle J., Krucker D., Lange W., Lenz T., Lidrych J., Lipka K., Lohmann W., Mankel R., Melzer-Pellmann I.-A., Meyer A.B., Meyer M., Missiroli M., Mnich J., Mussgiller A., Myronenko V., Perez Adan D., Pflitsch S.K., Pitzl D., Raspereza A., Saibel A., Savitskyi M., Scheurer V., Schutze P., Schwanenberger C., Shevchenko R., Singh A., Sosa Ricardo R.E., Tholen H., Turkot O., Vagnerini A., Van De Klundert M., Walsh R., Wen Y., Wichmann K., Wissing C., Zenaiev O., Zlebcik R., Aggleton R., Bein S., Benato L., Benecke A., Dreyer T., Ebrahimi A., Feindt F., Frohlich A., Garbers C., Garutti E., Gonzalez D., Gunnellini P., Haller J., Hinzmann A., Karavdina A., Kasieczka G., Klanner R., Kogler R., Kovalchuk N., Kurz S., Kutzner V., Lange J., Lange T., Malara A., Multhaup J., Niemeyer C.E.N., Reimers A., Rieger O., Schleper P., Schumann S., Schwandt J., Sonneveld J., Stadie H., Steinbruck G., Vormwald B., Zoi I., Akbiyik M., Baselga M., Baur S., Berger T., Butz E., Caspart R., Chwalek T., De Boer W., Dierlamm A., El Morabit K., Faltermann N., Giffels M., Gottmann A., Hartmann F., Heidecker C., Husemann U., Iqbal M.A., Kudella S., Maier S., Mitra S., Mozer M.U., Muller D., Musich M., Nurnberg A., Quast G., Rabbertz K., Savoiu D., Schafer D., Schnepf M., Schroder M., Shvetsov I., Simonis H.J., Ulrich R., Wassmer M., Weber M., Wohrmann C., Wolf R., Wozniewski S., Anagnostou G., Asenov P., Daskalakis G., Geralis T., Kyriakis A., Loukas D., Paspalaki G., Stakia A., Diamantopoulou M., Karathanasis G., Kontaxakis P., Manousakis-katsikakis A., Panagiotou A., Papavergou I., Saoulidou N., Theofilatos K., Vellidis K., Vourliotis E., Bakas G., Kousouris K., Papakrivopoulos I., Tsipolitis G., Zacharopoulou A., Evangelou I., Foudas C., Gianneios P., Katsoulis P., Kokkas P., Mallios S., Manitara K., Manthos N., Papadopoulos I., Strologas J., Triantis F.A., Tsitsonis D., Bartok M., Chudasama R., Csanad M., Major P., Mandal K., Mehta A., Pasztor G., Suranyi O., Veres G.I., Bencze G., Hajdu C., Horvath D., Sikler F., Veszpremi V., Vesztergombi G., Beni N., Czellar S., Karancsi J., Molnar J., Szillasi Z., Raics P., Teyssier D., Trocsanyi Z.L., Ujvari B., Csorgo T., Metzger W.J., Nemes F., Novak T., Choudhury S., Komaragiri J.R., Tiwari P.C., Bahinipati S., Kar C., Kole G., Mal P., Muraleedharan Nair Bindhu V.K., Nayak A., Sahoo D.K., Swain S.K., Bansal S., Beri S.B., Bhatnagar V., Chauhan S., Dhingra N., Gupta R., Kaur A., Kaur M., Kaur S., Kumari P., Lohan M., Meena M., Sandeep K., Sharma S., Singh J.B., Virdi A.K., Walia G., Bhardwaj A., Choudhary B.C., Garg R.B., Gola M., Keshri S., Kumar A., Naimuddin M., Priyanka P., Ranjan K., Shah A., Sharma R., Bhardwaj R., Bharti M., Bhattacharya R., Bhattacharya S., Bhawandeep U., Bhowmik D., Dutta S., Gomber B., Maity M., Mondal K., Nandan S., Purohit A., Rout P.K., Saha G., Sarkar S., Sharan M., Singh B., Thakur S., Behera P.K., Behera S.C., Kalbhor P., Muhammad A., Pradhan R., Pujahari P.R., Sikdar A.K., Dutta D., Jha V., Mishra D.K., Netrakanti P.K., Pant L.M., Shukla P., Aziz T., Bhat M.A., Dugad S., Mohanty G.B., Sur N., Verma R.K., Banerjee S., Chatterjee S., Das P., Guchait M., Karmakar S., Kumar S., Majumder G., Mazumdar K., Sahoo N., Sawant S., Dube S., Kansal B., Kapoor A., Kothekar K., Pandey S., Rane A., Rastogi A., Chenarani S., Etesami S.M., Khakzad M., Mohammadi Najafabadi M., Naseri M., Rezaei Hosseinabadi F., Felcini M., Grunewald M., Abbrescia M., Aly R., Calabria C., Colaleo A., Creanza D., Cristella L., De Filippis N., De Palma M., Di Florio A., Elmetenawee W., Fiore L., Gelmi A., Iaselli G., Ince M., Lezki S., Maggi G., Maggi M., Merlin J.A., Miniello G., My S., Nuzzo S., Pompili A., Pugliese G., Radogna R., Ranieri A., Selvaggi G., Silvestris L., Simone F.M., Venditti R., Verwilligen P., Abbiendi G., Battilana C., Bonacorsi D., Borgonovi L., Braibant-Giacomelli S., Campanini R., Capiluppi P., Castro A., Cavallo F.R., Ciocca C., Codispoti G., Cuffiani M., Dallavalle G.M., Fabbri F., Fanfani A., Fontanesi E., Giacomelli P., Grandi C., Guiducci L., Iemmi F., Lo Meo S., Marcellini S., Masetti G., Navarria F.L., Perrotta A., Primavera F., Rossi A.M., Rovelli T., Siroli G.P., Tosi N., Albergo S., Costa S., Di Mattia A., Potenza R., Tricomi A., Tuve C., Barbagli G., Cassese A., Ceccarelli R., Ciulli V., Civinini C., D'Alessandro R., Fiori F., Focardi E., Latino G., Lenzi P., Lizzo M., Meschini M., Paoletti S., Seidita R., Sguazzoni G., Viliani L., Benussi L., Bianco S., Piccolo D., Bozzo M., Ferro F., Mulargia R., Robutti E., Tosi S., Benaglia A., Beschi A., Brivio F., Ciriolo V., Dinardo M.E., Dini P., Gennai S., Ghezzi A., Govoni P., Guzzi L., Malberti M., Malvezzi S., Menasce D., Monti F., Moroni L., Paganoni M., Pedrini D., Ragazzi S., Tabarelli de Fatis T., Valsecchi D., Zuolo D., Buontempo S., Cavallo N., De Iorio A., Di Crescenzo A., Fabozzi F., Fienga F., Galati G., Iorio A.O.M., Layer L., Lista L., Meola S., Paolucci P., Rossi B., Sciacca C., Voevodina E., Azzi P., Bacchetta N., Bisello D., Boletti A., Bragagnolo A., Carlin R., Checchia P., De Castro Manzano P., Dorigo T., Dosselli U., Gasparini F., Gasparini U., Gozzelino A., Hoh S.Y., Margoni M., Meneguzzo A.T., Pazzini J., Presilla M., Ronchese P., Rossin R., Simonetto F., Tiko A., Tosi M., Zanetti M., Zotto P., Zucchetta A., Zumerle G., Braghieri A., Fiorina D., Montagna P., Ratti S.P., Re V., Ressegotti M., Riccardi C., Salvini P., Vai I., Vitulo P., Biasini M., Bilei G.M., Ciangottini D., Fano L., Lariccia P., Leonardi R., Manoni E., Mantovani G., Mariani V., Menichelli M., Rossi A., Santocchia A., Spiga D., Androsov K., Azzurri P., Bagliesi G., Bertacchi V., Bianchini L., Boccali T., Castaldi R., Ciocci M.A., Dell'Orso R., Donato S., Giannini L., Giassi A., Grippo M.T., Ligabue F., Manca E., Mandorli G., Messineo A., Palla F., Rizzi A., Rolandi G., Roy Chowdhury S., Scribano A., Spagnolo P., Tenchini R., Tonelli G., Turini N., Venturi A., Verdini P.G., Cavallari F., Cipriani M., Del Re D., Di Marco E., Diemoz M., Longo E., Meridiani P., Organtini G., Pandolfi F., Paramatti R., Quaranta C., Rahatlou S., Rovelli C., Santanastasio F., Soffi L., Tramontano R., Amapane N., Arcidiacono R., Argiro S., Arneodo M., Bartosik N., Bellan R., Bellora A., Biino C., Cappati A., Cartiglia N., Cometti S., Costa M., Covarelli R., Demaria N., Gonzalez Fernandez J.R., Kiani B., Legger F., Mariotti C., Maselli S., Migliore E., Monaco V., Monteil E., Monteno M., Obertino M.M., Ortona G., Pacher L., Pastrone N., Pelliccioni M., Pinna Angioni G.L., Romero A., Ruspa M., Salvatico R., Sola V., Solano A., Soldi D., Staiano A., Trocino D., Belforte S., Candelise V., Casarsa M., Cossutti F., Da Rold A., Della Ricca G., Vazzoler F., Zanetti A., Kim B., Kim D.H., Kim G.N., Lee J., Lee S.W., Moon C.S., Oh Y.D., Pak S.I., Sekmen S., Son D.C., Yang Y.C., Kim H., Moon D.H., Francois B., Kim T.J., Park J., Cho S., Choi S., Go Y., Ha S., Hong B., Lee K., Lee K.S., Lim J., Park S.K., Roh Y., Yoo J., Goh J., Kim H.S., Almond J., Bhyun J.H., Choi J., Jeon S., Kim J., Kim J.S., Lee H., Lee S., Nam K., Oh M., Oh S.B., Radburn-Smith B.C., Yang U.K., Yoo H.D., Yoon I., Jeon D., Kim J.H., Lee J.S.H., Park I.C., Watson I.J., Choi Y., Hwang C., Jeong Y., Lee Y., Yu I., Veckalns V., Dudenas V., Juodagalvis A., Rinkevicius A., Tamulaitis G., Vaitkus J., Mohamad Idris F., Wan Abdullah W.A.T., Yusli M.N., Zolkapli Z., Benitez J.F., Castaneda Hernandez A., Murillo Quijada J.A., Valencia Palomo L., Castilla-Valdez H., De La Cruz-Burelo E., Heredia-De La Cruz I., Lopez-Fernandez R., Sanchez-Hernandez A., Carrillo Moreno S., Oropeza Barrera C., Ramirez-Garcia M., Vazquez Valencia F., Eysermans J., Pedraza I., Salazar Ibarguen H.A., Uribe Estrada C., Morelos Pineda A., Mijuskovic J., Raicevic N., Krofcheck D., Bheesette S., Butler P.H., Lujan P., Ahmad A., Awan M.I.M., Hassan Q., Hoorani H.R., Khan W.A., Shah M.A., Shoaib M., Waqas M., Avati V., Grzanka L., Malawski M., Bialkowska H., Bluj M., Boimska B., Gorski M., Kazana M., Szleper M., Zalewski P., Bunkowski K., Byszuk A., Doroba K., Kalinowski A., Konecki M., Krolikowski J., Olszewski M., Walczak M., Araujo M., Bargassa P., Bastos D., Di Francesco A., Faccioli P., Galinhas B., Gallinaro M., Hollar J., Leonardo N., Niknejad T., Seixas J., Shchelina K., Strong G., Toldaiev O., Varela J., Afanasiev S., Ershov Y., Golunov A., Golutvin I., Gorbounov N., Gorbunov I., Kamenev A., Karjavine V., Korenkov V., Lanev A., Malakhov A., Matveev V., Moisenz P., Palichik V., Perelygin V., Shmatov S., Shulha S., Smirnov V., Voytishin N., Zarubin A., Chtchipounov L., Golovtcov V., Ivanov Y., Kim V., Kuznetsova E., Levchenko P., Murzin V., Oreshkin V., Smirnov I., Sosnov D., Sulimov V., Uvarov L., Vorobyev A., Andreev Y., Dermenev A., Gninenko S., Golubev N., Karneyeu A., Kirsanov M., Krasnikov N., Pashenkov A., Tlisov D., Toropin A., Epshteyn V., Gavrilov V., Lychkovskaya N., Nikitenko A., Popov V., Pozdnyakov I., Safronov G., Spiridonov A., Stepennov A., Toms M., Vlasov E., Zhokin A., Aushev T., Bychkova O., Chistov R., Danilov M., Polikarpov S., Tarkovskii E., Andreev V., Azarkin M., Dremin I., Kirakosyan M., Terkulov A., Belyaev A., Boos E., Ershov A., Gribushin A., Kaminskiy A., Kodolova O., Korotkikh V., Lokhtin I., Obraztsov S., Petrushanko S., Savrin V., Snigirev A., Vardanyan I., Barnyakov A., Blinov V., Dimova T., Kardapoltsev L., Skovpen Y., Azhgirey I., Bayshev I., Bitioukov S., Kachanov V., Konstantinov D., Mandrik P., Petrov V., Ryutin R., Slabospitskii S., Sobol A., Troshin S., Tyurin N., Uzunian A., Volkov A., Babaev A., Iuzhakov A., Okhotnikov V., Borchsh V., Ivanchenko V., Tcherniaev E., Adzic P., Cirkovic P., Dordevic M., Milenovic P., Milosevic J., Stojanovic M., Aguilar-Benitez M., Alcaraz Maestre J., Alvarez Fernandez A., Bachiller I., Barrio Luna M., Bedoya C.F., Brochero Cifuentes J.A., Carrillo Montoya C.A., Cepeda M., Cerrada M., Colino N., De La Cruz B., Delgado Peris A., Fernandez Ramos J.P., Flix J., Fouz M.C., Gonzalez Lopez O., Goy Lopez S., Hernandez J.M., Josa M.I., Moran D., Navarro Tobar A., Perez-Calero Yzquierdo A., Puerta Pelayo J., Redondo I., Romero L., Sanchez Navas S., Soares M.S., Triossi A., Willmott C., Albajar C., de Troconiz J.F., Reyes-Almanza R., Alvarez Gonzalez B., Cuevas J., Erice C., Fernandez Menendez J., Folgueras S., Gonzalez Caballero I., Palencia Cortezon E., Ramon Alvarez C., Rodriguez Bouza V., Sanchez Cruz S., Cabrillo I.J., Calderon A., Chazin Quero B., Duarte Campderros J., Fernandez M., Fernandez Manteca P.J., Garcia Alonso A., Gomez G., Martinez Rivero C., Martinez Ruiz del Arbol P., Matorras F., Piedra Gomez J., Prieels C., Ricci-Tam F., Rodrigo T., Ruiz-Jimeno A., Russo L., Scodellaro L., Vila I., Vizan Garcia J.M., Sonnadara D.U.J., Dharmaratna W.G.D., Wickramage N., Aarrestad T.K., Abbaneo D., Akgun B., Auffray E., Auzinger G., Baechler J., Baillon P., Ball A.H., Barney D., Bendavid J., Bianco M., Bocci A., Bortignon P., Bossini E., Brondolin E., Camporesi T., Caratelli A., Cerminara G., Chapon E., Cucciati G., d'Enterria D., Dabrowski A., Daci N., Daponte V., David A., Davignon O., De Roeck A., Deile M., Di Maria R., Dobson M., Dunser M., Dupont N., Elliott-Peisert A., Emriskova N., Fallavollita F., Fasanella D., Fiorendi S., Franzoni G., Fulcher J., Funk W., Giani S., Gigi D., Gill K., Glege F., Gouskos L., Gruchala M., Guilbaud M., Gulhan D., Hegeman J., Heidegger C., Iiyama Y., Innocente V., James T., Janot P., Karacheban O., Kaspar J., Kieseler J., Krammer M., Kratochwil N., Lange C., Lecoq P., Long K., Lourenco C., Malgeri L., Mannelli M., Massironi A., Meijers F., Mersi S., Meschi E., Moortgat F., Mulders M., Ngadiuba J., Niedziela J., Nourbakhsh S., Orfanelli S., Orsini L., Pantaleo F., Pape L., Perez E., Peruzzi M., Petrilli A., Petrucciani G., Pfeiffer A., Pierini M., Pitters F.M., Rabady D., Racz A., Rieger M., Rovere M., Sakulin H., Salfeld-Nebgen J., Scarfi S., Schafer C., Schwick C., Selvaggi M., Silva P., Snoeys W., Sphicas P., Steggemann J., Summers S., Tavolaro V.R., Treille D., Tsirou A., Van Onsem G.P., Vartak A., Verzetti M., Wozniak K.A., Zeuner W.D., Caminada L., Deiters K., Erdmann W., Horisberger R., Ingram Q., Kaestli H.C., Kotlinski D., Langenegger U., Rohe T., Backhaus M., Berger P., Calandri A., Chernyavskaya N., Dissertori G., Dittmar M., Donega M., Dorfer C., Gomez Espinosa T.A., Grab C., Hits D., Lustermann W., Manzoni R.A., Meinhard M.T., Micheli F., Musella P., Nessi-Tedaldi F., Pauss F., Perovic V., Perrin G., Perrozzi L., Pigazzini S., Ratti M.G., Reichmann M., Reissel C., Reitenspiess T., Ristic B., Ruini D., Sanz Becerra D.A., Schonenberger M., Shchutska L., Vesterbacka Olsson M.L., Wallny R., Zhu D.H., Amsler C., Botta C., Brzhechko D., Canelli M.F., De Cosa A., Del Burgo R., Kilminster B., Leontsinis S., Mikuni V.M., Neutelings I., Rauco G., Robmann P., Schweiger K., Takahashi Y., Wertz S., Kuo C.M., Lin W., Roy A., Sarkar T., Yu S.S., Chang P., Chao Y., Chen K.F., Chen P.H., Hou W.-S., Li Y., Lu R.-S., Paganis E., Psallidas A., Steen A., Asavapibhop B., Asawatangtrakuldee C., Srimanobhas N., Suwonjandee N., Bat A., Boran F., Celik A., Damarseckin S., Demiroglu Z.S., Dolek F., Dozen C., Dumanoglu I., Gokbulut G., Guler E.G., Guler Y., Hos I., Isik C., Kangal E.E., Kara O., Kayis Topaksu A., Kiminsu U., Onengut G., Ozdemir K., Simsek A.E., Tok U.G., Turkcapar S., Zorbakir I.S., Zorbilmez C., Isildak B., Karapinar G., Yalvac M., Atakisi I.O., Gulmez E., Kaya M., Kaya O., Ozcelik O., Tekten S., Yetkin E.A., Cakir A., Cankocak K., Komurcu Y., Sen S., Cerci S., Kaynak B., Ozkorucuklu S., Sunar Cerci D., Grynyov B., Levchuk L., Bhal E., Bologna S., Brooke J.J., Burns D., Clement E., Cussans D., Flacher H., Goldstein J., Heath G.P., Heath H.F., Kreczko L., Krikler B., Paramesvaran S., Sakuma T., Seif El Nasr-Storey S., Smith V.J., Taylor J., Titterton A., Bell K.W., Brew C., Brown R.M., Cockerill D.J.A., Coughlan J.A., Harder K., Harper S., Linacre J., Manolopoulos K., Newbold D.M., Olaiya E., Petyt D., Reis T., Schuh T., Shepherd-Themistocleous C.H., Thea A., Tomalin I.R., Williams T., Bainbridge R., Bloch P., Bonomally S., Borg J., Breeze S., Buchmuller O., Bundock A., Chahal G.S., Colling D., Dauncey P., Davies G., Della Negra M., Everaerts P., Hall G., Iles G., Komm M., Langford J., Lyons L., Magnan A.-M., Malik S., Martelli A., Milosevic V., Morton A., Nash J., Palladino V., Pesaresi M., Raymond D.M., Richards A., Rose A., Scott E., Seez C., Shtipliyski A., Stoye M., Strebler T., Tapper A., Uchida K., Virdee T., Wardle N., Webb S.N., Winterbottom D., Zecchinelli A.G., Zenz S.C., Cole J.E., Hobson P.R., Khan A., Kyberd P., Mackay C.K., Reid I.D., Teodorescu L., Zahid S., Brinkerhoff A., Call K., Caraway B., Dittmann J., Hatakeyama K., Madrid C., McMaster B., Pastika N., Smith C., Bartek R., Dominguez A., Uniyal R., Vargas Hernandez A.M., Buccilli A., Cooper S.I., Gleyzer S.V., Henderson C., Rumerio P., West C., Albert A., Arcaro D., Demiragli Z., Gastler D., Richardson C., Rohlf J., Sperka D., Spitzbart D., Suarez I., Sulak L., Zou D., Benelli G., Burkle B., Coubez X., Cutts D., Duh Y., Hadley M., Heintz U., Hogan J.M., Kwok K.H.M., Laird E., Landsberg G., Lau K.T., Narain M., Sagir S., Syarif R., Usai E., Wong W.Y., Yu D., Zhang W., Band R., Brainerd C., Breedon R., Calderon De La Barca Sanchez M., Chertok M., Conway J., Conway R., Cox P.T., Erbacher R., Flores C., Funk G., Jensen F., Ko W., Kukral O., Lander R., Mulhearn M., Pellett D., Pilot J., Shi M., Taylor D., Tos K., Tripathi M., Wang Z., Zhang F., Bachtis M., Bravo C., Cousins R., Dasgupta A., Florent A., Hauser J., Ignatenko M., Mccoll N., Nash W.A., Regnard S., Saltzberg D., Schnaible C., Stone B., Valuev V., Burt K., Chen Y., Clare R., Gary J.W., Ghiasi Shirazi S.M.A., Hanson G., Karapostoli G., Long O.R., Manganelli N., Olmedo Negrete M., Paneva M.I., Si W., Wimpenny S., Yates B.R., Zhang Y., Branson J.G., Cittolin S., Cooperstein S., Deelen N., Derdzinski M., Duarte J., Gerosa R., Gilbert D., Hashemi B., Klein D., Krutelyov V., Letts J., Masciovecchio M., May S., Padhi S., Pieri M., Sharma V., Tadel M., Wurthwein F., Yagil A., Zevi Della Porta G., Amin N., Bhandari R., Campagnari C., Citron M., Dutta V., Incandela J., Marsh B., Mei H., Ovcharova A., Qu H., Richman J., Sarica U., Stuart D., Wang S., Anderson D., Bornheim A., Cerri O., Dutta I., Lawhorn J.M., Lu N., Mao J., Newman H.B., Nguyen T.Q., Pata J., Spiropulu M., Vlimant J.R., Xie S., Zhang Z., Zhu R.Y., Alison J., Andrews M.B., Ferguson T., Mudholkar T., Paulini M., Sun M., Vorobiev I., Weinberg M., Cumalat J.P., Ford W.T., MacDonald E., Mulholland T., Patel R., Perloff A., Stenson K., Ulmer K.A., Wagner S.R., Alexander J., Cheng Y., Chu J., Datta A., Frankenthal A., Mcdermott K., Patterson J.R., Quach D., Ryd A., Tan S.M., Tao Z., Thom J., Wittich P., Zientek M., Abdullin S., Albrow M., Alyari M., Apollinari G., Apresyan A., Apyan A., Bauerdick L.A.T., Beretvas A., Berry D., Berryhill J., Bhat P.C., Burkett K., Butler J.N., Canepa A., Cerati G.B., Cheung H.W.K., Chlebana F., Cremonesi M., Elvira V.D., Freeman J., Gecse Z., Gottschalk E., Gray L., Green D., Grunendahl S., Gutsche O., Hanlon J., Harris R.M., Hasegawa S., Heller R., Hirschauer J., Jayatilaka B., Jindariani S., Johnson M., Joshi U., Klijnsma T., Klima B., Kortelainen M.J., Kreis B., Lammel S., Lewis J., Lincoln D., Lipton R., Liu M., Liu T., Lykken J., Maeshima K., Marraffino J.M., Mason D., McBride P., Merkel P., Mrenna S., Nahn S., O'Dell V., Papadimitriou V., Pedro K., Pena C., Ravera F., Reinsvold Hall A., Ristori L., Schneider B., Sexton-Kennedy E., Smith N., Soha A., Spalding W.J., Spiegel L., Stoynev S., Strait J., Taylor L., Tkaczyk S., Tran N.V., Uplegger L., Vaandering E.W., Vidal R., Wang M., Weber H.A., Woodard A., Acosta D., Avery P., Bourilkov D., Cadamuro L., Cherepanov V., Errico F., Field R.D., Guerrero D., Joshi B.M., Kim M., Konigsberg J., Korytov A., Lo K.H., Matchev K., Menendez N., Mitselmakher G., Rosenzweig D., Shi K., Wang J., Zuo X., Joshi Y.R., Adams T., Askew A., Habibullah R., Hagopian S., Hagopian V., Johnson K.F., Khurana R., Kolberg T., Martinez G., Perry T., Prosper H., Schiber C., Yohay R., Zhang J., Baarmand M.M., Hohlmann M., Noonan D., Rahmani M., Saunders M., Yumiceva F., Adams M.R., Apanasevich L., Betts R.R., Cavanaugh R., Chen X., Dittmer S., Evdokimov O., Gerber C.E., Hangal D.A., Hofman D.J., Kumar V., Mills C., Oh G., Roy T., Tonjes M.B., Varelas N., Viinikainen J., Wang H., Wang X., Wu Z., Alhusseini M., Bilki B., Dilsiz K., Durgut S., Gandrajula R.P., Haytmyradov M., Khristenko V., Koseyan O.K., Merlo J.-P., Mestvirishvili A., Moeller A., Nachtman J., Ogul H., Onel Y., Ozok F., Penzo A., Snyder C., Tiras E., Wetzel J., Yi K., Blumenfeld B., Cocoros A., Eminizer N., Gritsan A.V., Hung W.T., Kyriacou S., Maksimovic P., Mantilla C., Roskes J., Swartz M., Vami T.A., Baldenegro Barrera C., Baringer P., Bean A., Boren S., Bylinkin A., Isidori T., Khalil S., King J., Krintiras G., Kropivnitskaya A., Lindsey C., Mcbrayer W., Minafra N., Murray M., Rogan C., Royon C., Sanders S., Schmitz E., Tapia Takaki J.D., Williams J., Wilson G., Duric S., Ivanov A., Kaadze K., Kim D., Maravin Y., Mendis D.R., Mitchell T., Modak A., Mohammadi A., Rebassoo F., Wright D., Baden A., Baron O., Belloni A., Eno S.C., Feng Y., Hadley N.J., Jabeen S., Jeng G.Y., Kellogg R.G., Mignerey A.C., Nabili S., Seidel M., Skuja A., Tonwar S.C., Wang L., Wong K., Abercrombie D., Allen B., Bi R., Brandt S., Busza W., Cali I.A., D'Alfonso M., Gomez Ceballos G., Goncharov M., Harris P., Hsu D., Hu M., Klute M., Kovalskyi D., Lee Y.-J., Luckey P.D., Maier B., Marini A.C., Mcginn C., Mironov C., Narayanan S., Niu X., Paus C., Rankin D., Roland C., Roland G., Shi Z., Stephans G.S.F., Sumorok K., Tatar K., Velicanu D., Wang T.W., Wyslouch B., Chatterjee R.M., Evans A., Guts S., Hansen P., Hiltbrand J., Kubota Y., Lesko Z., Mans J., Revering M., Rusack R., Saradhy R., Schroeder N., Strobbe N., Wadud M.A., Acosta J.G., Oliveros S., Bloom K., Claes D.R., Fangmeier C., Finco L., Golf F., Kamalieddin R., Kravchenko I., Siado J.E., Snow G.R., Stieger B., Tabb W., Agarwal G., Harrington C., Iashvili I., Kharchilava A., McLean C., Nguyen D., Parker A., Pekkanen J., Rappoccio S., Roozbahani B., Alverson G., Barberis E., Freer C., Haddad Y., Hortiangtham A., Madigan G., Marzocchi B., Morse D.M., Nguyen V., Orimoto T., Skinnari L., Tishelman-Charny A., Wamorkar T., Wang B., Wisecarver A., Wood D., Bueghly J., Fedi G., Gilbert A., Gunter T., Hahn K.A., Odell N., Schmitt M.H., Sung K., Velasco M., Bucci R., Dev N., Goldouzian R., Hildreth M., Hurtado Anampa K., Jessop C., Karmgard D.J., Lannon K., Li W., Loukas N., Marinelli N., Mcalister I., Meng F., Musienko Y., Ruchti R., Siddireddy P., Smith G., Taroni S., Wayne M., Wightman A., Wolf M., Alimena J., Bylsma B., Cardwell B., Durkin L.S., Francis B., Hill C., Ji W., Lefeld A., Ling T.Y., Winer B.L., Dezoort G., Elmer P., Hardenbrook J., Haubrich N., Higginbotham S., Kalogeropoulos A., Kwan S., Lange D., Lucchini M.T., Luo J., Marlow D., Mei K., Ojalvo I., Olsen J., Palmer C., Piroue P., Stickland D., Tully C., Norberg S., Barker A., Barnes V.E., Chawla R., Das S., Gutay L., Jones M., Jung A.W., Mahakud B., Miller D.H., Negro G., Neumeister N., Peng C.C., Piperov S., Qiu H., Schulte J.F., Trevisani N., Wang F., Xiao R., Xie W., Cheng T., Dolen J., Parashar N., Baty A., Behrens U., Dildick S., Ecklund K.M., Freed S., Geurts F.J.M., Kilpatrick M., Padley B.P., Redjimi R., Roberts J., Rorie J., Shi W., Stahl Leiton A.G., Tu Z., Zhang A., Bodek A., de Barbaro P., Demina R., Dulemba J.L., Fallon C., Ferbel T., Galanti M., Garcia-Bellido A., Hindrichs O., Khukhunaishvili A., Ranken E., Taus R., Chiarito B., Chou J.P., Gandrakota A., Gershtein Y., Halkiadakis E., Hart A., Heindl M., Hughes E., Kaplan S., Laflotte I., Lath A., Montalvo R., Nash K., Osherson M., Salur S., Schnetzer S., Somalwar S., Stone R., Thomas S., Acharya H., Delannoy A.G., Spanier S., Bouhali O., Dalchenko M., Delgado A., Eusebi R., Gilmore J., Huang T., Kamon T., Luo S., Malhotra S., Marley D., Mueller R., Overton D., Pernie L., Rathjens D., Safonov A., Akchurin N., Damgov J., De Guio F., Hegde V., Kunori S., Lamichhane K., Mengke T., Muthumuni S., Peltola T., Undleeb S., Volobouev I., Whitbeck A., Greene S., Gurrola A., Janjam R., Johns W., Maguire C., Melo A., Ni H., Padeken K., Romeo F., Sheldon P., Tuo S., Velkovska J., Verweij M., Arenton M.W., Barria P., Cox B., Cummings G., Hakala J., Hirosky R., Joyce M., Ledovskoy A., Neu C., Tannenwald B., Wolfe E., Xia F., Harr R., Karchin P.E., Poudyal N., Sturdy J., Thapa P., Black K., Bose T., Buchanan J., Caillol C., Carlsmith D., Dasu S., De Bruyn I., Dodd L., Galloni C., He H., Herndon M., Herve A., Hussain U., Lanaro A., Loeliger A., Loveless R., Madhusudanan Sreekala J., Mallampalli A., Pinna D., Ruggles T., Savin A., Smith W.H., Teague D., Trembath-reichert S., Physics, Elementary Particle Physics, Faculty of Sciences and Bioengineering Sciences, Vriendenkring VUB, Belforte, S., Candelise, V., Casarsa, M., Cossutti, F., DA ROLD, A., DELLA RICCA, G., Vazzoler, F., Zanetti, A., and ET AL (the CMS, Collaboration)

Subjects
ComputerSystemsOrganization_COMPUTERSYSTEMIMPLEMENTATION, Proton, B physic, High energy physics, Experimental particle physics, LHC, CMS, Hadron-Hadron scattering (experiments), Higgs physics, p p: colliding beams, Higgs particle: pair production, bottom: 2, p p: scattering, Higgs particle: coupling, Higgs particle: hadroproduction, Higgs particle: decay modes, bottom: pair production, photon: pair production, top: pair production, coupling: Yukawa, coupling constant: upper limit, vector boson: fusion, mass spectrum: two-photon, Standard model, 5020 GeV-cms, Hadron, momentum spectrum [transverse momentum], QC770-798, 01 natural sciences, B physics, Physics, Particles & Fields, High Energy Physics - Experiment, transverse momentum: momentum spectrum, High Energy Physics - Experiment (hep-ex), ComputingMilieux_COMPUTERSANDEDUCATION, scattering [p p], [PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex], Nuclear Experiment, Physics, Quantum chromodynamics, Jet (fluid), 0105 Mathematical Physics, Large Hadron Collider, Luminosity (scattering theory), Settore FIS/01 - Fisica Sperimentale, QUARK, Monte Carlo [numerical calculations], bottom [jet], Nuclear & Particles Physics, Charged particle, angular dependence, CERN LHC Coll, Jet physics, Physical Sciences, 0202 Atomic, Molecular, Nuclear, Particle and Plasma Physics, PYTHIA, ComputingMethodologies_DOCUMENTANDTEXTPROCESSING, yield [charged particle], PARTICLE PHYSICS, colliding beams [p p], jet: bottom, numerical calculations: Monte Carlo, Particle Physics - Experiment, charged particle: yield, Nuclear and High Energy Physics, CERN Lab, Astrophysics::High Energy Astrophysical Phenomena, FOS: Physical sciences, yield [particle], 114 Physical sciences, Nuclear physics, Nuclear and particle physics. Atomic energy. Radioactivity, 0103 physical sciences, Nuclear Physics - Experiment, ddc:530, structure, 010306 general physics, 0206 Quantum Physics, Astrophysique, shape analysis: jet, particle: yield, Science & Technology, ComputingMilieux_THECOMPUTINGPROFESSION, hep-ex, LARGE HADRON COLLIDER, 010308 nuclear & particles physics, QCD, Física, Quark–gluon plasma, jet [shape analysis], High Energy Physics::Experiment, experimental results
Abstract

We present the first study of charged-hadron production associated with jets originating from b quarks in proton-proton collisions at a center-of-mass energy of 5.02 TeV. The data sample used in this study was collected with the CMS detector at the CERN LHC and corresponds to an integrated luminosity of 27.4 pb−1. To characterize the jet substructure, the differential jet shapes, defined as the normalized transverse momentum distribution of charged hadrons as a function of angular distance from the jet axis, are measured for b jets. In addition to the jet shapes, the per-jet yields of charged particles associated with b jets are also quantified, again as a function of the angular distance with respect to the jet axis. Extracted jet shape and particle yield distributions for b jets are compared with results for inclusive jets, as well as with the predictions from the pythia and herwig++ event generators., Journal of High Energy Physics, 2021 (5), ISSN:1126-6708, ISSN:1029-8479

Published
2021
Full Text
View/download PDF

33. OP0186 SENSITIVITY TO CHANGE OF DIFFERENT ULTRASOUND SCORES IN A PROSPECTIVE FOLLOW-UP OF NEW-ONSET TREATMENT-NAÏVE GCA PATIENTS

Author

B. D. Nielsen, P. Therkildsen, K. Keller, L. C. Gormsen, I. Hansen, and E. M. Hauge

Subjects
Rheumatology, Immunology, Immunology and Allergy, General Biochemistry, Genetics and Molecular Biology
Abstract

BackgroundThe role of ultrasound (US) for monitoring giant cell arteritis (GCA) is not clarified. Follow-up assessment of number of halos (halo count) and different quantitative scores based on intima media complex (IMC) measurement of halos, have demonstrated potential to show sensitivity to change(STC)12. Including IMC of normalized arteries in such scores may reduce the risk of missing new arteritic lesions and assessment bias towards a response.We aimed to evaluate US scores based on halo features and scores based on IMT measurements of all assessed arteries.ObjectivesTo compare different US score’s 1) STC after institution of treatment and 2) correlation with disease activity.MethodsIn a prospective cohort of new-onset GCA patient, pre-treatment diagnostic evaluation including US and PET/CT and subsequently temporal artery biopsy (TAB) was performed per protocol. All patients were started on 60 mg of prednisolone and followed a routine tapering. Follow-up visits including clinical evaluation, blood tests, US, the physician’s and patient’s global NRS (0-10) were performed after 8 weeks, 24 weeks and in a subgroup (n=24) at 15 months. US of temporal, carotid and axillary arteries included assessment of halo and IMC measurement in all arteries.For each visit, max IMC, max halo IMC, sum IMC, sum halo IMC, mean IMC and halo count were calculated for all and for temporal (TA) and large vessels (LV) separately. Accordingly, halo IMC scores only included positive arteries whereas other IMC scores included all arteries assessed.The change from baseline was assessed by Student’s t-test. Standard response means (SRM=meanΔ(visit-baseline)/SEΔ) were computed for each timepoint as STC estimates. Correlation with disease activity markers was assessed by Spearman’s correlation. A pResultsIn total 47 patients were included (60% women, mean (CI) age 67 (62-69) years, mean (CI) CRP 75 (63-89)). Baseline US was positive(+) in 94% (72% TA+, 72% LV+), PET/CT+ in 96% (77% cranial arteries, 85% large vessel vasculitis) and TAB+ in 72% of patients. All patients completed the per protocol planned follow-up visits. Two patients experienced a relapse at week 8 and 10 patients at week 24.All US outcomes improved during follow-up and was apparent by week 8 (Table 1) and forward. However, only scores including TA consistently showed statistically significant change from baseline to follow-up. In accordance the magnitude of change as expressed by SRM was large in TA, whereas SRM in LV was small (Figure 1).All TA based US scores showed significant moderate-strong correlation with disease activity markers (CRP, patient and physician global NRS). Some LV based US scored showed weak correlation with CRP but otherwise did not correlate with clinical disease activity.Figure 1.Table 1.US score changes during follow-upBaseline (IQR)Δw8 (SE)Δw24 (SE)Δm15 (SE)Halo countTA2 (0-4)-1.68 (.28)-1.70 (.30)-2.63 (.37)LV1 (0-2)-0.04 (.11)0.00 (.11)0.00 (.31)Total4 (2-6)-1.72 (.33)-1.70 (.34)-2.63 (.36)Sum IMCTA0.8 (0-1.8)-0.72 (.08)-0.69 (.11)-0.76 (.19)LV1.5 (0-2.8)-0.33 (.12)-0.13 (.11)-0.33 (.21)Total2.6 (1.6-4.4)-1.05 (.14)-0.81 (.15)-1.09 (.29)Sum halo IMCTA1.9 (1.6-2.5)-0.90 (.14)-0.90 (.17)-1.29 (.23)LV3.5 (2.8-4.0)-0.33 (.17)-0.15 (.14)-0.47 (.39)Total5.5 (4.6-6.3)-1.23 (.24)-1.04 (.24)-1.76 (.35)Max IMCTA0.5 (0.4-0.6)-0.17 (.03)-0.14 (.03)-0.17 (.05)LV1.2 (0.9-1.6)-0.16 (.06)-0.04 (.05)-0.20 (.09)Max halo IMCTA0.5 (0-0,6)-0.29 (.04)-0.26 (.05)-0.40 (.05)LV1.2 (0-1.6)-0.27 (.09)-0.09 (.08)-0.23 (.17)Mean IMCTA0.32 (0.27-0.43)-0.11 (.01)-0.10 (.02)-0.13 (.03)LV0.88 (0.7-1.03)-0.9 (0.3)-0.04 (.03)-0.10 (.05)Baseline medians, Δ mean difference from baseline. Bold indicates pConclusionSTC was maintained in US scores that included all assessed arteries hereby reducing potential assessment bias. These findings confirm US as a potential tool for monitoring treatment response.References[1]Ponte C, et al. Ann Rheum Dis 2021[2]Seitz L, et al. Rheumatology 2021AcknowledgementsThe authors would like to thank Morten Frydenberg for statistical support.Disclosure of InterestsBerit Dalsgaard Nielsen Speakers bureau: Roche, Paid instructor for: Roche, Consultant of: Sanofi, Philip Therkildsen: None declared, Kresten Keller: None declared, Lars Christian Gormsen: None declared, Ib Hansen: None declared, Ellen-Margrethe Hauge Speakers bureau: AbbVie, Sanofi, Sobi, MSD, UCB, Consultant of: AbbVie, Sanofi, Sobi, MSD, UCB, Grant/research support from: funding to Aarhus University Hospital from Roche, Novartis, Abbvie

Published
2022
Full Text
View/download PDF

34. POS0791 A NATIONWIDE STUDY OF OCULAR MANIFESTATIONS AMONG HOSPITALIZED PATIENTS WITH GIANT CELL ARTERITIS

Author

P. Therkildsen, A. De Thurah, M. Faurschou, B. Baslund, I. Hansen, M. Nørgaard, B. Dalsgaard Nielsen, and E. M. Hauge

Subjects
Rheumatology, Immunology, Immunology and Allergy, General Biochemistry, Genetics and Molecular Biology
Abstract

BackgroundOcular manifestations are common among patients with giant cell arteritis (GCA). Most feared is a permanent visual impairment reported in up to 15-20% of GCA patients1. Estimates of ocular manifestations vary significantly between studies, and large, nationwide studies are currently lacking. In GCA, visual impairment has been associated with high and low inflammatory markers2. Also, low-dose aspirin treatment has been associated with a reduced risk of visual impairment in patients with GCA3, but the evidence remains sparse.ObjectivesTo investigate the risk of ocular manifestations among hospitalized patients with GCA. Furthermore, to investigate the association between inflammatory marker levels and low-dose aspirin treatment with the risk of ocular manifestations.MethodsA Danish, nationwide, register-based cohort study including 14,574 incident GCA patients diagnosed between 1996 and 2018, and 145,740 general population referents, matched on age, sex, and calendar time. Ocular manifestations were defined as retinal vascular occlusions, disorders of opticus, visual impairment, diplopia, and amaurosis fugax. We tabulated characteristics of the GCA and reference cohort at the time of diagnosis including ocular manifestations recorded within one year of the GCA diagnosis. Regression analyses for incident ocular manifestations were performed using a pseudo-observational approach with the index date defined as the date of the GCA diagnosis. Cumulative incidence proportions (CIPs) and relative risks (RRs) of incident ocular manifestations with 95% confidence intervals (CIs) were calculated with death as a competing risk.ResultsWithin one year of the diagnosis, 1,026/14,574 (7%) of GCA patients were registered with ocular manifestations with 392/1,026 (38%) being prior to and 634/1,026 (62%) after the GCA diagnosis, and 744/1,026 (73%) were registered within one month of the diagnosis. A total of 336/1,026 (33%) were retinal vascular occlusions, 300/1,026 (29%) disorders of the opticus nerve, 177/1,026 (17%) visual impairment, 90/1,026 (9%) diplopia, and 123/1,026 (12%) amaurosis fugax. The CIP of ocular manifestations among GCA patients was 4.0% (95% CI: 3.6-4.3), 4.2% (95% CI: 3.9-4.6), and 4.6% (95% CI: 4.2-4.9) after 3, 6, and 12 months following the diagnosis with a 1-year RR of 28.0 (95% CI: 24.0-32.7) compared to the general population. Age above 70 years, male sex, and a positive temporal artery biopsy were associated with an increased 1-year RR of incident ocular manifestations. Neither treatment with low-dose aspirin nor baseline CRP nor ESR levels was related to the risk of ocular manifestations.ConclusionIn GCA, most cases of ocular manifestations occur at the time of diagnosis with over one-third of cases occurring prior to the diagnosis, emphasizing the need for early recognition and treatment. Low-dose aspirin treatment was not associated with a reduced risk of ocular manifestations among patients with GCA.References[1]González-Gay, M. A. et al. Visual Manifestations of Giant Cell Arteritis: Trends and Clinical Spectrum in 161 Patients. Medicine (Baltimore).79, 283–292 (2000)[2]Lopez-Diaz, M. J. et al. The Erythrocyte Sedimentation Rate Is Associated with the Development of Visual Complications in Biopsy-Proven Giant Cell Arteritis. Semin. Arthritis Rheum.38, 116–123 (2008)[3]Nesher, G. et al. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum.50, 1332–1337 (2004)Disclosure of InterestsPhilip Therkildsen: None declared, Annette de Thurah: None declared, Mikkel Faurschou: None declared, Bo Baslund: None declared, Ib Hansen: None declared, Mette Nørgaard: None declared, Berit Dalsgaard NIelsen: None declared, Ellen-Margrethe Hauge Speakers bureau: EMH has received honorariums and/or consulting fees from AbbVie, Sanofi, Sobi, and SynACT Pharma, Grant/research support from: Research grants to Aarhus University Hospital from Danish Regions Medicine Grants, Danish Rheumatism Association, Roche, Novartis, and Novo Nordic Foundation.

Published
2022
Full Text
View/download PDF

35. Impact of timing of birth and resident duty-hour restrictions on outcomes for small preterm infants

Author

Bell, Edward F., Nellie I. Hansen, Morriss, Frank H., Jr., Barbara J. Stoll, Namasivayam Ambalavanan, Gould, Jeffrey B., Laptook, Abbot R., Walsh, Michele C., Carlo, Waldemar A., Shankaran, Seetha, Das, Abhik, and Higgins, Rosemary D.

Subjects
Work hours -- Research, Residents (Medicine) -- Health aspects, Residents (Medicine) -- Training, Residents (Medicine) -- Research, Infants (Premature) -- Patient outcomes, Infants (Premature) -- Research, Morbidity -- Research
Published
2010

37. Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018

Author

Edward F, Bell, Susan R, Hintz, Nellie I, Hansen, Carla M, Bann, Myra H, Wyckoff, Sara B, DeMauro, Michele C, Walsh, Betty R, Vohr, Barbara J, Stoll, Waldemar A, Carlo, Krisa P, Van Meurs, Matthew A, Rysavy, Ravi M, Patel, Stephanie L, Merhar, Pablo J, Sánchez, Abbot R, Laptook, Anna Maria, Hibbs, C Michael, Cotten, Carl T, D'Angio, Sarah, Winter, Janell, Fuller, Abhik, Das, and Beena G, Sood

Subjects
Male, Cerebral Palsy, Infant, Newborn, Infant, Correction, Gestational Age, Infant, Premature, Diseases, General Medicine, United States, Enterocolitis, Necrotizing, Child, Preschool, Infant, Extremely Premature, Infant Mortality, Humans, Premature Birth, Female, Retinopathy of Prematurity, Hospital Mortality, Morbidity, Intracranial Hemorrhages, Bronchopulmonary Dysplasia
Abstract

Despite improvement during recent decades, extremely preterm infants continue to contribute disproportionately to neonatal mortality and childhood morbidity.To review survival, in-hospital morbidities, care practices, and neurodevelopmental and functional outcomes at 22-26 months' corrected age for extremely preterm infants.Prospective registry for extremely preterm infants born at 19 US academic centers that are part of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. The study included 10 877 infants born at 22-28 weeks' gestational age between January 1, 2013, and December 31, 2018, including 2566 infants born before 27 weeks between January 1, 2013, and December 31, 2016, who completed follow-up assessments at 22-26 months' corrected age. The last assessment was completed on August 13, 2019. Outcomes were compared with a similar cohort of infants born in 2008-2012 adjusting for gestational age.Extremely preterm birth.Survival and 12 in-hospital morbidities were assessed, including necrotizing enterocolitis, infection, intracranial hemorrhage, retinopathy of prematurity, and bronchopulmonary dysplasia. Infants were assessed at 22-26 months' corrected age for 12 health and functional outcomes, including neurodevelopment, cerebral palsy, vision, hearing, rehospitalizations, and need for assistive devices.The 10 877 infants were 49.0% female and 51.0% male; 78.3% (8495/10848) survived to discharge, an increase from 76.0% in 2008-2012 (adjusted difference, 2.0%; 95% CI, 1.0%-2.9%). Survival to discharge was 10.9% (60/549) for live-born infants at 22 weeks and 94.0% (2267/2412) at 28 weeks. Survival among actively treated infants was 30.0% (60/200) at 22 weeks and 55.8% (535/958) at 23 weeks. All in-hospital morbidities were more likely among infants born at earlier gestational ages. Overall, 8.9% (890/9956) of infants had necrotizing enterocolitis, 2.4% (238/9957) had early-onset infection, 19.9% (1911/9610) had late-onset infection, 14.3% (1386/9705) had severe intracranial hemorrhage, 12.8% (1099/8585) had severe retinopathy of prematurity, and 8.0% (666/8305) had severe bronchopulmonary dysplasia. Among 2930 surviving infants with gestational ages of 22-26 weeks eligible for follow-up, 2566 (87.6%) were examined. By 2-year follow-up, 8.4% (214/2555) of children had moderate to severe cerebral palsy, 1.5% (38/2555) had bilateral blindness, 2.5% (64/2527) required hearing aids or cochlear implants, 49.9% (1277/2561) had been rehospitalized, and 15.4% (393/2560) required mobility aids or other supportive devices. Among 2458 fully evaluated infants, 48.7% (1198/2458) had no or mild neurodevelopmental impairment at follow-up, 29.3% (709/2419) had moderate neurodevelopmental impairment, and 21.2% (512/2419) had severe neurodevelopmental impairment.Among extremely preterm infants born in 2013-2018 and treated at 19 US academic medical centers, 78.3% survived to discharge, a significantly higher rate than for infants born in 2008-2012. Among infants born at less than 27 weeks' gestational age, rehospitalization and neurodevelopmental impairment were common at 2 years of age.

Published
2022
Full Text
View/download PDF

38. Surgery-Associated Infections among Infants Born Extremely Preterm

Author

Andi L. Shane, Myra H. Wyckoff, Pablo J. Sánchez, Nellie I. Hansen, Mohannad Moallem, and Barbara J. Stoll

Subjects
medicine.medical_specialty, business.industry, Extremely preterm, Gestational age, medicine.disease, Surgery, Bacteremia, Pediatrics, Perinatology and Child Health, Epidemiology, medicine, Observational study, business, Prospective cohort study, Meningitis, Fungemia
Abstract

Objective To assess the burden of invasive infection following surgery (surgery-associated infections [SAI]) among infants born extremely premature. Study design This was an observational, prospective study of infants born at gestational age 22-28 weeks hospitalized for >3 days, between April 1, 2011, to March 31, 2015, in academic centers of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. SAI was defined by culture-confirmed bacteremia, fungemia, or meningitis ≤14 days following a surgical procedure. Results Of 6573 infants, 1154 (18%) who underwent surgery were of lower gestational age (mean [SD]: 25.5 [1.6] vs 26.2 [1.6], P Conclusions Surgical procedures were associated with bacteremia, fungemia, or meningitis in 7% of infants. The epidemiology of invasive postoperative infections as described in this report may inform the selection of empiric antimicrobial therapy and postoperative preventive care.

Published
2022
Full Text
View/download PDF

39. Genetic identification of macroalgal species on Japanese tsunami marine debris and genetic comparisons with their wild populations

Author

Hiroshi Kawai, Gayle I. Hansen, and Takeaki Hanyuda

Subjects
0106 biological sciences, Aquatic Science, Oceanography, 010603 evolutionary biology, 01 natural sciences, Ceramium sungminbooi, Japan, Invasion, Macroalgae, Marine debris, Earthquakes, Ecosystem, Tsunami debris, Genetic marker, Shore, Waste Products, geography.geographical_feature_category, Pacific Ocean, biology, Ecology, 010604 marine biology & hydrobiology, Water Pollution, Species diversity, Sequence Analysis, DNA, Great East Japan Earthquake, biology.organism_classification, Seaweed, Pollution, Polysiphonia, Geography, Tsunamis, Identification (biology), Environmental Monitoring
Abstract

Since 2012 a huge amount of marine debris caused by the 2011 Great East Japan Earthquake and Tsunami has been arriving on Northeastern Pacific shores. Often healthy macroalgae were attached to them, which may become introduced to the Northwestern Pacific coasts and disturb their ecosystems. In order to elucidate the diversity of those macroalgae, and to establish a basis for detecting their new introduction to Northwestern Pacific coasts, we have examined their species diversity by morphology and genetic identifications. We have obtained gene sequences for 205 specimens, and identified 49 species as Japanese Tsunami Marine Debris (JTMD) macroalgae. Most of them are known to be distributed in Japan and showed identical or very closely related genetic types to those of Tohoku, and confirmed to be originated from the area. Several species such as Ceramium sungminbooi , Ectocarpus crouaniorum , Polysiphonia koreana , etc. have not been reported from Japan, but this is explained by the shortage of taxonomic information.

Published
2018

40. Diagnostic test accuracy, inter- and intrarater reliability of a knee osteoarthritis machine learning decision-aid algorithm in a near-clinical setting

Author

Martin Axelsen, Mikael Boesen, Rikke Bachmann, Mathias Willadsen Brejnebøl, Ulrik Ratjen, I. Hansen, Michael Lundemann, Philip Hansen, and Janus Damm

Subjects
Computer science, business.industry, Biomedical Engineering, Diagnostic test, Osteoarthritis, Intra-rater reliability, medicine.disease, Machine learning, computer.software_genre, Rheumatology, medicine, Orthopedics and Sports Medicine, Artificial intelligence, business, computer
Published
2021
Full Text
View/download PDF

42. Neonatal sepsis in rural India: timing, microbiology and antibiotic resistance in a population-based prospective study in the community setting

Author

Pravas R. Misra, Radhanath Satpathy, Dinesh S. Chandel, Arjit Mohapatra, Pinaki Panigrahi, Nidhi Sharma, Nandita Banaji, Rama Chaudhry, Judith A. Johnson, Subhranshu S. Mohapatra, John Glenn Morris, Ira H. Gewolb, Lingaraj Pradhan, Nellie I. Hansen, Sarah Kandefer, and Sailajanandan Parida

Subjects
Male, Staphylococcus aureus, medicine.medical_specialty, Population, India, Drug resistance, Article, Microbiology, 03 medical and health sciences, 0302 clinical medicine, Antibiotic resistance, Klebsiella, 030225 pediatrics, medicine, Humans, 030212 general & internal medicine, Neonatology, Disease management (health), education, Intensive care medicine, Prospective cohort study, education.field_of_study, Neonatal sepsis, business.industry, Incidence, Incidence (epidemiology), Infant, Newborn, Disease Management, Obstetrics and Gynecology, Drug Resistance, Microbial, medicine.disease, Anti-Bacterial Agents, 3. Good health, Pediatrics, Perinatology and Child Health, Female, Neonatal Sepsis, business
Abstract

Objective To examine the timing and microbiology of neonatal sepsis in a population-based surveillance in the Indian community setting. Study Design All live born infants in 223 villages of Odisha state were followed at home for 60 days. Suspect sepsis cases were referred to study hospitals for further evaluation including blood culture. Results Of 12,622 births, 842 were admitted with suspected sepsis of whom 95% were 4–60 days old. Culture confirmed incidence of sepsis was 6.7/1000 births with 51% Gram negatives (Klebsiella predominating) and 26% Gram positives (mostly Staphylococcus aureus). A very high level of resistance to penicillin and ampicillin, moderate resistance to cephalosporins, and extremely low resistance to Gentamicin and Amikacin was observed. Conclusion The bacterial burden of sepsis in the Indian community is not high. Judicious choice of empiric antibiotics, antibiotic stewardship, and alternate modalities should be considered for the management or prevention of neonatal sepsis in India.

Published
2017
Full Text
View/download PDF

43. P.332 Vortioxetine for emotional blunting in patients with major depression and insufficient response to previous antidepressant treatment: the COMPLETE study

Author

Ioana Florea, Andrea Fagiolini, M. Christensen, and I. Hansen

Subjects
Pharmacology, Vortioxetine, medicine.medical_specialty, business.industry, Emotional blunting, Psychiatry and Mental health, Neurology, Medicine, Antidepressant, Pharmacology (medical), In patient, Neurology (clinical), business, Psychiatry, Biological Psychiatry, Depression (differential diagnoses)
Published
2020
Full Text
View/download PDF

44. Piloting the Use of a Short Observation List for ASD-Symptoms in Day-Care: Challenges and Further Possibilities

Author

Trond H. Diseth, Ulla I. Hansen, Synnve Schjølberg, Kenneth Larsen, and Astrid Aasland

Subjects
Male, medicine.medical_specialty, Psychometrics, Autism Spectrum Disorder, Early detection, Day care, behavioral disciplines and activities, 03 medical and health sciences, 0302 clinical medicine, mental disorders, Developmental and Educational Psychology, medicine, Humans, 0501 psychology and cognitive sciences, Child, Public health, 05 social sciences, Repeated measures design, Child Day Care Centers, medicine.disease, Early Diagnosis, Autism spectrum disorder, Clinical diagnosis, Child, Preschool, Autism, Female, Psychology, 030217 neurology & neurosurgery, 050104 developmental & child psychology, Clinical psychology
Abstract

Early symptoms of autism spectrum disorder (ASD) develop through the second year of life, making a stable ASD diagnosis possible around 24 months of age. However, in general, children with ASD are diagnosed later. In this study we explored the use of a short observation list to detect symptoms associated with ASD in children 12–24 months of age attending typical day-care centers. The results indicate that a short observation list used by day-care teachers does not reveal sufficient properties to be independently used in young children in day-care centers. Further studies should explore multiple and repeated measures for early detection of symptoms associated with ASD in typical day-care centers.

Published
2019

45. Impact of Early-Onset Sepsis and Antibiotic Use on Death or Survival with Neurodevelopmental Impairment at 2 Years of Age among Extremely Preterm Infants

Author

Nellie I. Hansen, Scott A. Lorch, Karen M. Puopolo, Eric C. Eichenwald, C. Michael Cotten, Barbara J. Stoll, Pablo J. Sánchez, Sagori Mukhopadhyay, Sara B. DeMauro, Edward F. Bell, and Rachel G. Greenberg

Subjects
Male, Pediatrics, medicine.medical_specialty, Time Factors, medicine.drug_class, Antibiotics, Risk Assessment, Article, Sepsis, Cohort Studies, 03 medical and health sciences, symbols.namesake, 0302 clinical medicine, 030225 pediatrics, medicine, Humans, 030212 general & internal medicine, Poisson regression, Age of Onset, Retrospective Studies, business.industry, Retrospective cohort study, medicine.disease, Anti-Bacterial Agents, Survival Rate, Neurodevelopmental Disorders, Relative risk, Child, Preschool, Infant, Extremely Premature, Pediatrics, Perinatology and Child Health, Propensity score matching, Necrotizing enterocolitis, symbols, Gestation, Female, business
Abstract

Objective To evaluate the hypothesis that early-onset sepsis increases risk of death or neurodevelopmental impairment (NDI) among preterm infants; and that among infants without early-onset sepsis, prolonged early antibiotics alters risk of death/NDI. Study design Retrospective cohort study of infants born at the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network centers (2006-2014) at 22-26 weeks of gestation and birth weight 401-1000 g. Early-onset sepsis defined as growth of a pathogen from blood or cerebrospinal fluid culture ≤72 hours after birth. Prolonged early antibiotics was defined as antibiotics initiated ≤72 hours and continued ≥5 days without culture-confirmed infection, necrotizing enterocolitis, or spontaneous perforation. Primary outcome was death before follow-up or NDI assessed at 18-26 months corrected age. Poisson regression was used to estimate adjusted relative risk (aRR) and CI for early-onset sepsis outcomes. A propensity score for receiving prolonged antibiotics was derived from early clinical factors and used to match infants (1:1) with and without prolonged antibiotic exposure. Log binomial models were used to estimate aRR for outcomes in matched infants. Results Among 6565 infants, those with early-onset sepsis had higher aRR (95% CI) for death/NDI compared with infants managed with prolonged antibiotics (1.18 [1.06-1.32]) and to infants without prolonged antibiotics (1.23 [1.10-1.37]). Propensity score matching was achieved for 4362 infants. No significant difference in death/NDI (1.04 [0.98-1.11]) was observed with or without prolonged antibiotics among the matched cohort. Conclusions Early-onset sepsis was associated with increased risk of death/NDI among extremely preterm infants. Among matched infants without culture-confirmed infection, prolonged early antibiotic administration was not associated with death/NDI.

Published
2019

47. Neurodevelopmental and Growth Outcomes of Extremely Preterm Infants with Short Bowel Syndrome

Author

Ira Adams-Chapman, Andrea F. Duncan, Mercedes M. Bell, Conrad R. Cole, Nellie I. Hansen, and Susan R. Hintz

Subjects
Adult, Male, Short Bowel Syndrome, Pediatrics, medicine.medical_specialty, Developmental Disabilities, Gestational Age, Comorbidity, Infant, Premature, Diseases, Bayley Scales of Infant Development, Article, 03 medical and health sciences, symbols.namesake, 0302 clinical medicine, Enterocolitis, Necrotizing, 030225 pediatrics, Humans, Medicine, 030212 general & internal medicine, Poisson regression, Toddler, Retrospective Studies, business.industry, Extremely preterm, Infant, Short bowel syndrome, medicine.disease, Intestinal Perforation, Case-Control Studies, Child, Preschool, Infant, Extremely Premature, Relative risk, Pediatrics, Perinatology and Child Health, Necrotizing enterocolitis, symbols, Gestation, Female, business
Abstract

To determine if preterm infants with surgical necrotizing enterocolitis (sNEC) or spontaneous intestinal perforation (SIP) with short bowel syndrome (SBS) have worse neurodevelopmental and growth outcomes than those with sNEC/SIP without SBS, and those with no necrotizing enterocolitis, SIP, or SBS.We undertook a retrospective analysis of prospectively collected data from infants born between 22 and 26 weeks of gestation in the National Institute of Child Health and Human Development Neonatal Research Network centers from January 1, 2008, to December 31, 2016. Survivors were assessed at 18-26 months corrected age by standardized neurologic examination and Bayley Scales of Infant and Toddler Development, Third Edition. The primary outcome was moderate-severe neurodevelopmental impairment. Growth was assessed using World Health Organization z-score standards. Adjusted relative risks were estimated using modified Poisson regression models.Mortality was 32%, 45%, and 21% in the 3 groups, respectively. Eighty-nine percent of survivors were seen at 18-26 months corrected age. Moderate-severe neurodevelopmental impairment was present in 77% of children with SBS compared with 62% with sNEC/SIP without SBS (adjusted relative risk, 1.22; 95% CI, 1.02-1.45; P = .03) and 44% with no necrotizing enterocolitis, SIP, or SBS (adjusted relative risk, 1.60; 95% CI, 1.37-1.88; P .001). Children with SBS had lowcognitive, language, and motor scores than children with sNEC/SIP without SBS. At follow-up, length and head circumference z-scores remained more than 1 SD below the mean for children with SBS.Preterm infants with sNEC/SIP and SBS had increased risk of adverse neurodevelopmental outcomes at 18-26 months corrected age and impaired growth compared with peers with sNEC/SIP without SBS or without any of these conditions.

Published
2021
Full Text
View/download PDF

48. Heimatkunde

Author

T. Schaberg, I. Hansen-Schaberg, and K. Müller-Scheeßel

Subjects
Pulmonary and Respiratory Medicine
Published
2016
Full Text
View/download PDF

49. Early-Onset Neonatal Sepsis 2015 to 2017, the Rise of Escherichia coli, and the Need for Novel Prevention Strategies

Author

Kristi L. Watterberg, Krisa P. Van Meurs, Carl T. D'Angio, Michele C. Walsh, Waldemar A. Carlo, Myra H. Wyckoff, Karen M. Puopolo, Monica V. Collins, Gregory M Sokol, Bradley A. Yoder, Brenda B. Poindexter, Pablo J. Sánchez, Nellie I. Hansen, Uday Devaskar, Rosemary D. Higgins, Edward F. Bell, Carol J. Baker, Stephanie J. Schrag, Abbot R. Laptook, Barbara J. Stoll, Abhik Das, S. Nadya J. Kazzi, Ellen C. Hale, and C. Michael Cotten

Subjects
Male, Pediatrics, medicine.medical_specialty, Birth weight, Gestational Age, Group B, 03 medical and health sciences, 0302 clinical medicine, 030225 pediatrics, Ampicillin, Escherichia coli, medicine, Humans, Prospective Studies, 030212 general & internal medicine, Prospective cohort study, Escherichia coli Infections, Original Investigation, Neonatal sepsis, business.industry, Incidence, Incidence (epidemiology), Infant, Newborn, Correction, Gestational age, medicine.disease, United States, Practice Guidelines as Topic, Pediatrics, Perinatology and Child Health, Female, Gentamicin, Neonatal Sepsis, business, Infant, Premature, medicine.drug
Abstract

Importance Early-onset sepsis (EOS) remains a potentially fatal newborn condition. Ongoing surveillance is critical to optimize prevention and treatment strategies. Objective To describe the current incidence, microbiology, morbidity, and mortality of EOS among a cohort of term and preterm infants. Design, setting, and participants This prospective surveillance study included a cohort of infants born at a gestational age (GA) of at least 22 weeks and birth weight of greater than 400 g from 18 centers of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network from April 1, 2015, to March 31, 2017. Data were analyzed from June 14, 2019, to January 28, 2020. Main outcomes and measures Early-onset sepsis defined by isolation of pathogenic species from blood or cerebrospinal fluid culture within 72 hours of birth and antibiotic treatment for at least 5 days or until death. Results A total of 235 EOS cases (127 male [54.0%]) were identified among 217 480 newborns (1.08 [95% CI, 0.95-1.23] cases per 1000 live births). Incidence varied significantly by GA and was highest among infants with a GA of 22 to 28 weeks (18.47 [95% CI, 14.57-23.38] cases per 1000). No significant differences in EOS incidence were observed by sex, race, or ethnicity. The most frequent pathogens were Escherichia coli (86 [36.6%]) and group B streptococcus (GBS; 71 [30.2%]). E coli disease primarily occurred among preterm infants (68 of 131 [51.9%]); GBS disease primarily occurred among term infants (54 of 104 [51.9%]), with 24 of 45 GBS cases (53.3%) seen in infants born to mothers with negative GBS screening test results. Intrapartum antibiotics were administered to 162 mothers (68.9%; 110 of 131 [84.0%] preterm and 52 of 104 [50.0%] term), most commonly for suspected chorioamnionitis. Neonatal empirical antibiotic treatment most frequently included ampicillin and gentamicin. All GBS isolates were tested, but only 18 of 81 (22.2%) E coli isolates tested were susceptible to ampicillin; 6 of 77 E coli isolates (7.8%) were resistant to both ampicillin and gentamicin. Nearly all newborns with EOS (220 of 235 [93.6%]) displayed signs of illness within 72 hours of birth. Death occurred in 38 of 131 infected infants with GA of less than 37 weeks (29.0%); no term infants died. Compared with earlier surveillance (2006-2009), the rate of E coli infection increased among very low-birth-weight (401-1500 g) infants (8.68 [95% CI, 6.50-11.60] vs 5.07 [95% CI, 3.93-6.53] per 1000 live births; P = .008). Conclusions and relevance In this study, EOS incidence and associated mortality disproportionately occurred in preterm infants. Contemporary cases have demonstrated the limitations of current GBS prevention strategies. The increase in E coli infections among very low-birth-weight infants warrants continued study. Ampicillin and gentamicin remained effective antibiotics in most cases, but ongoing surveillance should monitor antibiotic susceptibilities of EOS pathogens.

Published
2020
Full Text
View/download PDF

50. Prolonged duration of early antibiotic therapy in extremely premature infants

Author

Rachel G, Greenberg, Dhuly, Chowdhury, Nellie I, Hansen, P Brian, Smith, Barbara J, Stoll, Pablo J, Sánchez, Abhik, Das, Karen M, Puopolo, Sagori, Mukhopadhyay, Rosemary D, Higgins, and C Michael, Cotten

Subjects
Male, Infant, Extremely Premature, Infant, Newborn, Humans, Female, United States, Article, Anti-Bacterial Agents, Retrospective Studies
Abstract

Prolonged early antibiotics in extremely premature infants may have negative effects. We aimed to assess prevalence and outcomes of provision of prolonged early antibiotics to extremely premature infants in the absence of culture-confirmed infection or NEC.Cohort study of infants from 13 centers born without a major birth defect from 2008-2014 who were 401-1000 grams birth weight, 22-28 weeks gestation, and survived ≥5 days without culture-confirmed infection, NEC, or spontaneous intestinal perforation. We determined the proportion of infants who received prolonged early antibiotics, defined as ≥5 days of antibiotic therapy started at ≤72 h of age, by center and over time. Associations between prolonged early antibiotics and adverse outcomes were assessed using multivariable logistic regression.A total of 5730 infants were included. The proportion of infants receiving prolonged early antibiotics varied from 30-69% among centers and declined from 49% in 2008 to 35% in 2014. Prolonged early antibiotics was not significantly associated with death (adjusted odds ratio 1.17 [95% CI: 0.99-1.40], p = 0.07) and was not associated with NEC.The proportion of extremely premature infants receiving prolonged early antibiotics decreased, but significant center variation persists. Prolonged early antibiotics were not significantly associated with increased odds of death or NEC.

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results